How many investments has Canaan Partners made?

Canaan Partners has 369 tracked investments, 103 of which have exited via acquisition or IPO, including 21 dated in the last 24 months.

What stage does Canaan Partners invest at?

Canaan Partners invests at the Pre-Seed, Seed, Series A stages.

What is Canaan Partners's typical check size?

Canaan Partners typically writes checks of $500K – $20M.

Where is Canaan Partners located?

Canaan Partners is headquartered in Stamford, US.

Does Canaan Partners lead rounds?

Yes, Canaan Partners leads investment rounds.

Who does Canaan Partners co-invest with?

Canaan Partners most often shares deals with Connecticut Innovations, Evolution VC Partners, New Enterprise Associates (NEA), among 594 tracked co-investors.

Canaan Partners

Venture capital

Stamford · Pre-Seed–Series A · 32 people tracked

Also known as CANAAN MANAGEMENT, LLC · Canaan Natural Gas Management, Llc

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Canaan Partners

5,166 people in our graph share verified history with the Canaan Partners team — schools, employers, funds. One of them is your warm intro.

Wesley Chanunlockedknows Maha Ibrahim · together at Massachusetts Institute of Technology (overlapped)

knows the team · via Instacart

×6knows the team · via Stanford University

×2knows the team · via Massachusetts Institute of Technology

knows the team · via Cornell

knows the team · via Bowdoin College

✨ Fox Verdict

Investment thesis

Canaan emphasizes a personal, non-formulaic approach to venture investing, drawing on values built over three decades. The firm prizes high performance with low ego, favoring understated and effective partners over self-promotion. It values a diverse team whose varied backgrounds inform a collective approach spanning industries, generations, and geographies. Canaan positions the full team's network and operational resources behind each portfolio company, helping with recruiting, go-to-market, and strategic pivots. The firm treats founders with respect, transparency, and honesty, viewing portfolio companies like family and tying its own success to theirs. It aims to stay closely informed and add value while knowing when to step back and let founders lead.

Invests inBiotech Cloud Computing Consumer Deep Tech Digital Health E-commerce Enterprise Software Fintech Gaming Healthtech Medical Devices North America Stamford United States

Source: firm website, verified Sep 15, 2026.

Stage

Pre-Seed–Series A

Check

$500K – $20M

Stamford, Connecticut, US

Leads rounds

Leads

Instruments

Equity

Founded

1994

Last 12 months

14 investments

AUM

$7B

VC funds

Tracked investments

435

Team · 32 people

from the firm's website & curated & public directories

Hrach Simonian· General Partner· Menlo Park, California, United Statesin 𝕏

Hrach Simonian, an engineer-turned-investor, applies hardware and physics expertise to evaluate complex technical products, focuses on marketplace-driven efficiency, helped build his firm's West Coast presence, and sits on Instacart's board.

John Pacifico· COO + CFO and General Partner· New Yorkin 𝕏

John Pacifico joined a healthcare venture team at 20 and pairs CEO experience launching two biosurgical companies as investor with inventing FDA‑cleared surgical products and leading over $1.75B in fundraising.

Joydeep Bhattacharyya· General Partner· Menlo Park, Californiain 𝕏

Joydeep Bhattacharyya has founding-era Office 365 and Skype for Business experience running R&D, IT and support, sits on Dragos's board, and writes for immigrant entrepreneurs on cross-border company building.

Laura Chau· General Partner· New York, New Yorkin 𝕏

Laura Chau is a General Partner at Canaan Partners focusing on consumer and commerce technology investments. She holds a degree from Stanford Graduate School of Business and was recognized as a Forbes 30 Under 30 alumna. Her investment experience spans software-driven companies, artificial intelligence applications, and technology-enabled operations.

Nina Kjellson· General Partner· Menlo Park, Californiain 𝕏

Nina Kjellson brings a Nordic perspective to biotech, focusing on therapeutics for serious underserved conditions like addiction and neurological disease, and champions women in healthcare and tech via WoVen podcast

Brendan Dickinson· General Partner· New York Cityin 𝕏

Brendan Dickinson is an investor at Canaan Partners who has spent roughly a decade focused on fintech. He proposes categorizing fintech companies as financial platforms, financial product manufacturers, and financial infrastructure providers. He references Canaan's investment activity in the space, including the firm having led LendingClub's Series A.

b•••@canaan.comreveal

Brent Ahrens· General Partner· Menlo Park, Californiain

Brent Ahrens, a longtime West Coast healthcare lead since 1999, uniquely combines deep biopharma and medtech investing with a Kauffman Fellows background and active mentorship of new VCs.

b•••@canaan.comreveal

Colleen Cuffaro· Partner· New Haven, Connecticutin 𝕏

Colleen Cuffaro is a healthcare investor at Canaan Partners focused on biopharma companies pursuing transformative, scalable drug technologies such as small molecules and antibodies. She led Canaan's investment in Arrakis Therapeutics and holds a background connected to Yale. Her investment interest centers on companies addressing unmet medical needs through broadly applicable and scalable approaches.

c•••@canaan.comreveal

Deepak Kamra· General Partner· Menlo Park, Californiain 𝕏

Deepak Kamra has been at one firm since 1991, investing through market cycles and was an early Silicon Valley institutional backer of commercial space such as Skybox Imaging in 2012.

d•••@canaan.comreveal

John Balen· General Partner· Menlo Park, California, United Statesin 𝕏

Venture Advisory Network member; General Partner at Canaan Partners.

j•••@canaan.comreveal

Maha Ibrahim· General Partner· Menlo Park, Californiain 𝕏

Maha Ibrahim, longest-tenured GP with 20+ years' experience and a PhD in Economics, uses market-structure analysis to back category-defining data/infrastructure startups and guides founders on fit and longer runways.

m•••@canaan.comreveal

Stephen Bloch· General Partner· Westport, Connecticutin 𝕏

Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.

s•••@canaan.comreveal

Tim Shannon· General Partner· Westport, Connecticutin 𝕏

Physician-turned-investor trained in pulmonary and critical care; former CuraGen CEO Tim Shannon founded and led Arvinas—pioneering targeted protein degradation—and often serves as board chair shaping scientific strategy and development plans.

t•••@canaan.comreveal

Wende Hutton· General Partner· Menlo Park, Californiain 𝕏

Wende Hutton is a General Partner at Canaan Partners, where she has invested for over 25 years across medtech, biopharma, and healthcare IT. She began her career at Nellcor (now Medtronic), spent two years in operations at a biotech company, and made biopharma investments at Mayfield Fund before joining Canaan in 2004 as a medtech specialist. She studied human biology and physiology in college and takes a hands-on approach to building teams and strategy at her portfolio companies.

w•••@canaan.comreveal

Guy Russo· General Partner· San Francisco, Californiain

Guy Russo offers over three decades of continuous finance, operations, and administration leadership—CFO and Administrative General Partner since 1997—with a CPA and MBA in Accounting, based in Overland Park, Kansas.

Kieran Chacko· Venture Partner· New York, New York, United Statesin

Kieran Chacko is a Venture Partner at Canaan. He has more than 15 years of experience working with startup, small, mid-market, and enterprise businesses across the fintech, payments, and not-for-profit sectors, with a focus on SaaS platforms. His background includes leading marketing, sales, business development, and account management teams, and he serves as a board member for technology startups and non-profit organizations.

Antonio Lepore· White Plains, New York, United Statesin

Dana Malman Warren· Venture Partner· Rye, New York, United Statesin

Dana Malman Warren joined Canaan as a venture partner, focusing on fintech and adjacent tech sectors while working with the firm's portfolio and ecosystem partners. She previously headed global strategic platform partnerships at Stripe, where she led partnerships with companies including Shopify, Salesforce, Mindbody, and XERO, and held executive roles at American Express and PayPal. She has also advised startups, including Anthropic, on scaling their business and teams.

Evan Teiger

Felipe Ossio· New York, New York, United Statesin

Felipe Ossio serves as VP, Talent at Primary Venture Partners. His experience spans the People function, including HR business partner work, diversity, equity, and inclusion, performance management, engagement, and learning and development, alongside talent acquisition.

Howard Greenfield· Atlanta Metropolitan Areain

Janet Bell· Analyst· Menlo Park, Californiain

Paul Fonteyne· Fairfield, Connecticut, United Statesin

Rich Boyle· General Partner· Menlo Park, Californiain 𝕏

Rich Boyle, who led LoopNet to IPO and its near-$1B CoStar sale, backs proptech and robotics founders building full‑stack, production‑scale automation for warehouses, construction and aerospace (Hermeus).

Uwe Schoenbeck· Westport, Connecticut, United Statesin

Uwe Schoenbeck is a Senior Associate at Primary Venture Partners, where he works as an investor. His investment focus spans companies across the compute value chain. He is based in New York City.

Peter Farina· Executive in Residence / East Coast· New Yorkin

Peter Farina is an Executive in Residence at Canaan focused on healthcare, working with entrepreneurs and scientists to develop innovative medicines. He previously served as Senior Vice President of Development at Boehringer Ingelheim Pharmaceuticals and holds a Ph.D. in organic chemistry from SUNY Buffalo.

p•••@canaan.comreveal

Bridget Flaherty· Senior Associate· New York, New York, United Statesin

Sarah Housman· Vice President· Williamstown, Massachusetts, United Statesin

Founder mafia

The Canaan Partners mafia →

9 people who came through Canaan Partners went on to found or lead other companies.

Anne DeGheestExecutive in ResidenceFounded Healthtechcapital Sarah SclarsicInvestment ProfessionalFounded Getaround Stephen BlochGeneral PartnerFounded Allyx Therapeutics, Inc.Tim ShannonGeneral PartnerFounded Quarry Thera Kieran ChackoVenture PartnerFounded Harbinger Health Dana Malman WarrenVenture PartnerFounded Sendoso John PacificoCOO + CFO and General PartnerFounded Abyrx Paul FonteyneFounded Allyx Therapeutics, Inc.Scott GrimesPrincipalFounded Cardlytics

What they invest in

from 234 of 435 portfolio companies

Biotech ×71AI & Machine Learning ×61Healthtech ×59SaaS ×52Enterprise Software ×39Fintech ×33Medical Devices ×32Data & Infrastructure ×23

HQs:United States×184United Kingdom×10Canada×3Nigeria×3Belgium×2Germany×2

Who they back

founder profiles across 128 portfolio companies

54%

solo founders

69 of 128 mapped founding teams

43%

repeat founders

of 146 founders with career history

~3 yrs

old at investment

median across 67 dated deals

Founding team size:solo founder×692 founders×433 founders×94+ founders×7

Where their founders studiedfrom 133 founders with education data

University of California, Berkeley ×7Massachusetts Institute of Technology ×5Stanford University Graduate School of Business ×5University of Illinois Urbana-Champaign ×5Cornell ×4Stanford University ×4University of Pennsylvania ×4Columbia University ×3

What their founders studiedfrom 135 founders with field-of-study data

Engineering ×41Computer Science ×38Business & Management ×22Economics ×14Finance & Accounting ×13Medicine ×7Life Sciences ×6Mathematics & Statistics ×6

Where their founders worked beforefrom 146 founders with career history

Stanford University ×5AOL ×4YPO ×4Apple ×3Cisco ×3Goldman Sachs ×3PubMatic ×3White Ops ×3

Accelerator rootsportfolio companies that came through a program

Y Combinator ×6 Techstars ×2

25 founders hold a PhD · 28 hold an MBA (of 141 with degree data)

Investments · 435 tracked

founders shown can be your intro path

By year:2026 · 10 2025 · 16 2024 · 11 2023 · 3 2022 · 4 2021 · 17 2020 · 9 2019 · 3 2018 · 7 2017 · 9 2016 · 8 2015 · 22135 dated

Arvinas Holding Co. LLCarvinas.com in 𝕏NASDAQ: ARVNOct 2015

Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology.

BiotechHealthtechNew Haven, US

Sean Cassidy(Executive Officer)inManuel Litchman(Executive Officer, Director)inRandy Teel(President and Chief Executive Officer; Director)in

BoardStephen Squinto(Director)in Liam Ratcliffe(Director)in

Board seat Tim Shannon· per SEC Form D

Co-investors5AM Ventures Access Biotechnology Connecticut Innovations Nextech Invest RA Capital Solasta Ventures +1 more

Cardlyticscardlytics.com in 𝕏NASDAQ: CDLXMay 2017

Cardlytics operates a commerce media platform that uses card-linked purchase data to deliver targeted offers and closed-loop measurement for marketers and advertisers, and personalized rewards programs for banks and publishers.

AdTechFintechMarketing TechAtlanta, US

Scott Grimes(Executive Officer, Director)in Lynne Laube(Executive Officer, Director)in Kirk Somers(Executive Officer)inDavid Evans(Executive Officer)in

BoardJohn Klinck(Director)inMark Johnson(Director)in

Board seat John Balen· per SEC Form D

Co-investorsBaroda Ventures Kinetic Ventures, L.L.C.Next Coast Ventures Savano Capital Partners Discovery Capital Hyperplane Venture Capital +2 more

CytomXcytomx.com in 𝕏NASDAQ: CTMXDec 2014

CytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue.

BiotechHealthtechSouth San Francisco, US

Sean McCarthy(Executive Officer, Director)inSean A. McCarthy(Chief Executive Officer and Chairman)inMarcia P. Belvin(SVP, Chief Scientific Officer)inDawn Benson(SVP, Quality and Product Manufacturing)inWayne Chu(Chief Medical Officer)Rachael Lester(SVP, Chief Business Officer)in

Board seat Tim Shannon· per SEC Form D

Co-investorsLongitude Capital Pfizer Venture Investments OrbiMed Third Rock Ventures

Liquidia Corporationliquidia.com inNASDAQ: LQDAApr 2021

Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

BiotechMorrisville, US

Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in

Board Paul B. Manning(Director)inJoanna Horobin(Director)Raman Singh(Director)

Board seat Stephen Bloch· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)PBM Capital

Liquidia TechnologiesNASDAQ: LQDAFeb 2018SEC filingmedium confidence

Liquidia Technologies is a biopharmaceutical company that develops and commercializes drugs for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, including YUTREPIA, an inhaled dry-powder treprostinil formulation, and treprostinil injection through a profit-sharing arrangement with Sandoz, along with pipeline candidates based on its PRINT particle-engineering platform.

BiotechMorrisville, US

Kevin Gordon(President and Chief Financial Officer)Robert Lippe(Chief Operations Officer)Benjamin Maynor(Senior Vice President, Research and Development)Timothy Albury(Executive Officer)Neal F. Fowler(Chief Executive Officer)Roger A. Jeffs(Chief Executive Officer)

Board seat Stephen Bloch· per SEC Form D · $22.4M raise · filed Jan 2020

Co-investorsPappas Capital

NextCurenextcure.comNASDAQ: NXTCDec 2015

Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.

BiotechBeltsville, US

Michael Richman(Executive Officer, Director)Timothy Mayer(Executive Officer)inUdayan Guha(Executive Officer)inSteven P. Cobourn(Executive Officer)inSourav Kundu(Executive Officer)inKevin Shaw(Executive Officer)in

Board seat Tim Shannon· per SEC Form D

Co-investorsBay City Capital LAV Lilly Asia Ventures Pfizer Venture Investments Quan Capital Sofinnova Ventures +4 more

Rallybio HoldingsNASDAQ: RLYBMar 2020

Rallybio is a clinical-stage biotechnology company developing therapies for severe and rare diseases, with a lead program in RLYB116, a C5 complement inhibitor in clinical development, and a preclinical program in RLYB332, a matriptase-2 antibody for iron overload disorders.

HealthtechFarmington, US

Jeffrey M. Fryer(Executive Officer, Director)Martin W. Mackay(Executive Officer, Director)Stephen Uden(Executive Officer, Director)

Board seat Tim Shannon· per SEC Form D

Co-investors5AM Ventures Pivotal Life Sciences

TYRA Biosciencestyra.bio inNASDAQ: TYRAFeb 2024

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.

BiotechHealthtechCarlsbad, US

Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)inAlan Fuhrman(Executive Officer)in

Board Robert More(Director)

Board seat Nina Kjellson· per SEC Form D

Co-investorsAlta Partners BioBrit Nextech Invest NEXTECH ONCOLOGY SCSP RA Capital

Aevaaeva.com in 𝕏NASDAQ: AEVAJan 2017

Aeva develops FMCW-based 4D LiDAR sensors and perception software that measure velocity and range simultaneously, using silicon photonics to put LiDAR elements on a chip.

HardwareMobility & TransportationSemiconductorsPalo Alto, US

SOROUSH SALEHIAN DARDASHTI(Executive Officer, Director)MINA REZK(Executive Officer, Director)in Soroush Salehian(CEO and Cofounder)in

BoardSHAHIN FARSHCHI(Director)Yuan Chen(Capital Allocator)in Simon Mahony(Investor)

Co-investorsLux Capital Next47 Socii Capital

DexComdexcom.com inNASDAQ: DXCMMay 2016

Dexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Richard Doubleday(Executive Officer)Steven R. Pacelli(Executive Officer)inJeffrey Moy(Executive Officer)Terrance H. Gregg(Executive Officer, Director)Jorge Valdes(Executive Officer)inJohn D. Lister(Executive Officer)in

Ideaya Biosciencesideayabio.com in 𝕏NASDAQ: IDYA

IDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

Yujiro Hata(Executive Officer, Director)Paul Stone(Executive Officer)in

Board Timothy Shannon(Director)in John Diekman(Director)inTerry Rosen(Director)Jeffrey Stein(Director)

Co-investors5AM Ventures Nextech Invest Biotechnology Value Fund WuXi Healthcare Ventures

Instacartinstacart.com in 𝕏NASDAQ: CART

Instacart operates a marketplace connecting grocery retailers with customers who order food and household items for same-day delivery or in-store pickup, serving millions of households across North America through partnerships with over 350 retailers.

ConsumerE-commerceFoodTechSan Francisco, US

Apoorva Mehta(Founder & CEO)in Brandon Leonardo(Founder)in Max Mullen(Founder)in

Co-investorsA*Andreessen Horowitz BACKGROUND CAPITAL Bling Capital Bright Pixel Capital Coatue Management +29 more

Matchmatch.comNASDAQ: MTCH

Gary Kremen(Founder)in Spencer Rascoff in

Protagonist Therapeuticsprotagonist-inc.com in 𝕏NASDAQ: PTGXJul 2015

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

BiotechHealthtechMilpitas, US

Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)Dinesh V. Patel(President and Chief Executive Officer)

BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)

Co-investorsAisling Capital JJDC Lilly Ventures RA Capital Starfish Ventures

Rallybio, LLCrallybio.com in 𝕏NASDAQ: RLYB

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Stephen Uden(Founder)inMartin(Co-Founder & Chairman)Jon(Chief Financial Officer)

Co-investors5AM Ventures Connecticut Innovations F-Prime Capital Mitsui Global Investment Solasta Ventures Pivotal Life Sciences

Arrakis Therapeuticsarrakistx.com in 𝕏Feb 2017✓ verified

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

Michael Gilman(Executive Officer, Director)inMark DeLong(CEO)inDavid Neafus(Executive Officer)inRussell C. Petter(Executive Officer)

Board Alan E. Walts(Director)in

Board seat Colleen Cuffaro· per SEC Form D

Co-investorsPfizer Ventures Advent Life Sciences Nextech Invest OUP (Osage University Partners)Pfizer Venture Investments venBio Partners +1 more

Iantrekiantrekmed.com inOct 2020✓ verified

Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.

BiotechHealthtechMedical DevicesElkins Park, US

Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)

Board Jeffry K Weinhuff(Director)Farrell Tyson(Director)

Board seat Stephen Bloch· per SEC Form D

Co-investorsaMoon Visionary Ventures Civilization Ventures Management, Llc FemHealth Ventures JSD Capital, LLC US Venture Partners

Nocion Therapeuticsnociontx.com in 𝕏Dec 2025✓ verified

Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.

BiotechHealthtechMedical DevicesWatertown, US

MATTHEW FRANKEL(Executive Officer)inPETER COUROSSI(Executive Officer)RICHARD BATYCKY(Executive Officer, Director)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)inCHRISTOPHER SILBER(Executive Officer)in

Board seatJulie Grant· per SEC Form D

Co-investorsF-Prime Capital Mission Biocapital Monograph Capital Partners OUP (Osage University Partners)Osage University Partners

Vivace Therapeuticsvivacetherapeutics.comFeb 2025✓ verified

Vivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types.

BiotechHealthtechMedical DevicesSan Mateo, US

Shuang Qiao(Executive Officer, Director)Sheng Ding(Executive Officer)

BoardEdward Hu(Director)Jun Wu(Director)Jake Simson(Director)in

Board seat Tim Shannon· per SEC Form D

Co-investorsRA Capital Cenova Capital Mission Biocapital

Acesion Pharma ApSacesionpharma.com in✓ verified

Acesion Pharma is a biotech company developing pharmaceutical treatments.

BiotechHealthtechMedical DevicesCopenhagen, DK

Ulrik Sørensen(COO & Co-founder)in Morten Grunnet(CSO & Co-founder)inAnders Gaarsdal Holst(CEO & CMO)inTorgeir Vaage(CFO)in

Co-investorsAlpha Wave Global Novo Holdings Broadview Ventures Global BioAccess Fund

AttoTudeattotude.com in✓ verified

AttoTude develops optical interconnect technology for data centers to support artificial intelligence and exascale computing applications.

AI & Machine LearningData & InfrastructureDeep TechHardwareMenlo Park, US

Joy Laskar(AttoTude Founder and CTO)inDave Welch(AttoTude Founder and CEO)in

BoardPeter Wagner(Director)Basil Alwan(Director)

Co-investorsThe Westly Group Sutter Hill Ventures Mayfield Fund NosTerra Venture Capital Open Field Capital Wing +1 more

Clutchclutch.ca in 𝕏✓ verified

Clutch is an online platform for buying and selling used cars in Canada, offering pricing, inspection, e-contracting, financing, and delivery through software built in-house.

E-commerceMarketplacesMobility & Transportation

Stephen Seibel(Founder & President)in Dan Park(Chief Executive Officer)inAnshul Ruparell(Chief Financial Officer)Richard Ball(Chief Production Officer)

Co-investorsAltos Ventures Panache Ventures Upper90 Alkeon Capital Andreessen Horowitz BMO Capital Partners +9 more

Curileumcurileum.com in✓ verified

Curileum develops regenerative medicine therapies targeting intestinal stem cells to prevent colorectal cancer.

BiotechHealthtechMedical DevicesLondon, GB

Dr Jeff Moore(Founder & CEO)

Co-investorsAtlas Venture Biotechnology Value Fund Prospect Venture Partners Oxford Technology Management

Draig Therapeuticsdraigtherapeutics.com in✓ verified

Draig develops neuropsychiatric therapies targeting glutamate and GABA pathways through AMPA and GABAA receptor modulators, serving patients with neuropsychiatric disorders.

BiotechDeep TechDigital HealthMedical DevicesCardiff, GB

John Atack(Head of Biology & Founder)in Simon Ward(Chief Scientific Officer & Founder)in

Co-investorsAccess Biotechnology Sanofi Ventures SV Health Investors SR One Capital Management British Business Bank Janus Henderson Investors

ThirtyFiveBio Limitedthirtyfivebio.com in✓ verified

ThirtyFiveBio is a drug discovery company developing GPR35 antagonists to treat gastrointestinal diseases, with a focus on ulcerative colitis by targeting epithelial dysfunction.

BiotechDigital HealthHealthtechOxford, GB

James Westcott(CEO)in

Tizona Therapeutics, Inc.tizonatx.com✓ verified

Tizona Therapeutics is a biotechnology company developing first-in-class immuno-oncology therapeutics, including its lead clinical-stage asset TTX-080, aimed at changing cancer progression and relapse.

AI & Machine LearningBiotechHealthtech

Vijay K. Kuchroo(Scientific Co-Founder & Advisory Board Member)Drew Pardoll(Scientific Co-Founder & Advisory Board Member)Dario Vignali(Scientific Co-Founder & Advisory Board Member)Jedd Wolchok(Scientific Co-Founder & Advisory Board Member)Christine O'Brien(Chief Executive Officer & Board Member)inCourtney Beers(Chief Scientific Officer)

Co-investorsMPM BioImpact Abingworth Gilead Sciences Astellas Venture Management LLC Lightstone Ventures

Trishula Therapeutics, Inc.trishulatx.com in✓ verified

Trishula Therapeutics is a clinical-stage biopharmaceutical company developing TTX-030, a first-in-class anti-CD39 antibody for advanced cancers.

BiotechHealthtech

Anil Singhal(President and CEO)inSiddhartha Mitra(Chief Medical Officer)in

Co-investorsMPM BioImpact Astellas Venture Management LLC Lightstone Ventures

Aer Therapeuticsaertherapeutics.com inJan 2025

Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma.

BiotechHealthtechMedical DevicesRaleigh, US

Thomas Mathers(Executive Officer, Director)inJames Shaffer(Executive Officer, Director)John Fahy(Director)in

Board Christy Shaffer(Director)inRishi Gupta(Director)

Board seat Tim Shannon· per SEC Form D

Co-investorsHatteras Venture Partners OrbiMed Pappas Capital

Agile Stacksagilestacks.comDec 2016

San Mateo, US

Indra Mohan(Director)John Mathon(Executive Officer, Director)

Board seat Maha Ibrahim· per SEC Form D

Co-investorsAlumni Ventures Basecamp Fund Blue Ivy Ventures Castor Ventures (an Alumni Ventures Fund)Launch Angels Funds Rosecliff Ventures

Alchera inOct 2021SEC filingmedium confidence

HealthtechWalnut Creek, US

Lester John Lloyd(Previously CEO, now Chairman & Director.)Andrew Thomas Lloyd(General Counsel, Corp Sec'y)Ken Traverso(CEO, Director)Donald Shirley(President, Director)Timothy Patrick Lloyd(CTO, Director)

Board seat Wende Hutton· per SEC Form D · filed Nov 2021

Alphina Therapeuticsalphinatx.comFeb 2026

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)inRanjit Bindra(Director)

Board Matthew Cohen(Director)in

Board seat Colleen Cuffaro· per SEC Form D

Co-investorsConnecticut Innovations HighCape Capital OUP (Osage University Partners)

Annum HealthOct 2016Defunct

Evidence-based teletherapy platform addressing alcohol use disorder.

HealthtechNew York, US

Lauren Wolfe(Executive Officer)Mark Willenbring(Executive Officer)Michael Laskoff(Executive Officer, Director, Promoter)

BoardManish Agarwal(Director)Miki Kapoor(Director)

Board seat Nina Kjellson· per SEC Form D

Co-investors.406 Ventures ARC Angel Fund AXA Venture Partners Elevate Innovation Partners

Antiva Biosciencesantivabio.com inMay 2015 · $53M

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.

BiotechFemTechHealthtechMedical DevicesRedwood City, US

Karl Y. Hostetler(Executive Officer, Director)inGail Maderis(Director)in Kristine Ball(President & CEO)inElaine Chien(Executive Officer)inSarah Walter(Executive Officer)inRaju Gadiraju(Executive Officer)in

Board seat Wende Hutton· per SEC Form D

Co-investorsAdjuvant Capital Brace Pharma Lumira Ventures MPM BioImpact OUP (Osage University Partners)Sofinnova Ventures +3 more

Apex Aiapex.ai inNov 2018

Apex.AI develops safety-certified, scalable software for mobility systems, including its Apex.OS product (with Apex.Grace runtime SDK and Apex.Ida communication middleware) to help build software-defined vehicles.

AI & Machine LearningDeveloper ToolsMobility & TransportationRoboticsSaaSPalo Alto, US

Jan Becker(Executive Officer, Director, Promoter)inDejan Pangercicin

Board seat Rayfe Gaspar-Asaoka· per SEC Form D

Co-investorsLightspeed Venture Partners Volvo Group Venture Capital AB Airbus Ventures InMotion Ventures Toyota Ventures Webb Investment Network

Butterfly HealthApr 2015SEC filingmedium confidence

Advanced ManufacturingLos Gatos, US

Kelly Lewis Brezoczky(Executive Officer, Director)Paul Crawley(Executive Officer)

BoardDavid Alberga(Director)Karl P Ronn(Director)

Board seat Wende Hutton· per SEC Form D · $3.1M raise · filed May 2015

Cargomaticcargomatic.comJan 2015

Cargomatic operates a marketplace that connects shippers with carriers for local freight, drayage, intermodal, LTL, and full-truckload trucking across the top 20 US ports.

B2B MarketplacesLogistics & Supply ChainMobility & TransportationMarina Del Rey, US

Brett Parker(Executive Officer, Director)Jonathan Kessler(Executive Officer, Director)in

Board seat Hrach Simonian· per SEC Form D

Co-investorsAcequia Capital (AceCap)eGateway Capital Green Meadow Ventures Kombo Ventures Rachel Zoe Ventures RPS Ventures +10 more

Chrono Therapeuticschronothera.comAug 2016

HealthtechHayward, US

GUY DIPIERRO(Director)ALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)

BoardELIZABETH ROCKETT(Director)

Board seat Wende Hutton· per SEC Form D

Co-investorsEmergent Medical Partners, LLP Fountain Healthcare Partners Kaiser Permanente Ventures Mission Bay Capital 5AM Ventures GE Ventures

Cidara Therapeuticscidara.com in 𝕏Feb 2015SEC filingmedium confidence

Pharmaceutical company developing medicines and vaccines for patient health and treatment.

BiotechHealthtechSan Diego, US

Jeffrey Stein(Executive Officer, Director)Kevin Judice(Director)inKevin Forrest(Executive Officer)Dirk Thye(Executive Officer)inKen Bartizal(Executive Officer)inPaul Daruwala(Executive Officer)in

Board seat Nina Kjellson· per SEC Form D · $42M raise · filed Feb 2015

Co-investors5AM Ventures Aisling Capital Bain Capital Life Sciences Frazier Life Sciences RA Capital Vivo Capital +1 more

Clutch Technologies Inc.Jan 2025SEC filingmedium confidence

Toronto

DAN PARK(Executive Officer, Director)STEPHEN SEIBEL(Executive Officer)

Board Anshul Ruparell(Director)in

Board seat Laura Chau· per SEC Form D · $40.4M raise · filed Jan 2025

Co-investorsFJ Labs

Confetti CollectiveJan 2019SEC filingmedium confidence

New York, US

Sara Raffa(Executive Officer, Director)Linden Ellis(Executive Officer, Director)

Board seat Laura Chau· per SEC Form D · $2.3M raise · filed Feb 2019

Day One Biopharmaceuticalsdayonebio.com in 𝕏Feb 2021

Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors.

BiotechHealthtechSouth San Francisco, US

Jeremy Bender(Executive Officer, Director)

Board Michael Gladstone(Director)in Derek DiRocco(Director)inJulie Papanek Grant(Director)inJohn Josey(Director)Daniel Becker(Director)

Board seatJulie Grant· per SEC Form D

Co-investorsAccess Biotechnology Atlas Venture RA Capital The Column Group

Dicom Grid inMar 2016

Phoenix, US

MORRIS PANNER(Executive Officer, Director)inMICHAEL PALIN(Chief Financial Officer)inGEOFFREY CRAWSHAW(Executive Officer)

BoardSTEPHEN PAPADOPOULOS(Director)JAMES RAMSEY(Director)

Board seat Stephen Bloch· per SEC Form D

Dragos websitedragos.com inOct 2018

Dragos provides cybersecurity software, threat intelligence, and professional services to protect operational technology (OT), IT, and IoT assets in industrial environments.

CybersecurityDefense TechEnterprise SoftwareHanover, US

Robert M. Lee(CEO and co-founder)in

Board seat Joydeep Bhattacharyya· per SEC Form D

Co-investorsAllegisCyber Capital BYU Cougar Capital Cyber Mentor Fund DataTribe Earth Foundry Energy Foundry +9 more

Eiger BiopharmaceuticalsApr 2011SEC filingmedium confidence

BiotechSanta Clara, US

Jeffrey Glenn(Director)David Cory(Executive Officer, Director)

BoardEd Engleman(Director)

Board seat Nina Kjellson· per SEC Form D · $3M raise · filed Apr 2016

Co-investorsPfizer Venture Investments Vivo Capital

EndoGastric Solutionsendogastricsolutions.com in 𝕏Apr 2015

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.

BiotechHealthtechMedical DevicesSan Mateo, US

Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)

Board Michael Carusi(Director)inArda Minocherhomjee(Director)

Board seat Brent Ahrens· per SEC Form D

Co-investorsAccelmed Partners Evidity Health Capital Lightstone Ventures VCFA Group De Novo Ventures FOUNDATION MEDICAL PARTNERS +1 more

Envisia Therapeutics inOct 2015SEC filingmedium confidence

BiotechMorrisville, US

Ben Yerxa(Executive Officer)in Eric Linsley(Executive Officer)in

Board Ed Mathers(Director)inSeth Rudnick(Director)inNeal Fowler(Director)

Board seat Stephen Bloch· per SEC Form D · $5.1M raise · filed Oct 2015

Co-investorsNew Enterprise Associates (NEA)Pappas Capital

Even Financialevenfinancial.com inFeb 2017Acquired

Even Financial, operating as Engine, runs a financial services marketplace and matching network that connects consumers with financial products through APIs and white-labeled experiences.

AI & Machine LearningFintechMarketplacesBrooklyn, US

Phill Rosen(Founder & CEO)Ian Rosen(Executive Officer, Director)Jarid Maged(Executive Officer, Director)

Board seat Brendan Dickinson· per SEC Form D

Co-investorsAAF Management Ltd.Conversion Capital F-Prime Capital GreatPoint Ventures MassMutual Ventures Valuestream Ventures +4 more

Fast LabsMar 2014SEC filingmedium confidence

Marina Del Rey, US

Matt Munson(Executive Officer, Director)

BoardMat Ellis(Director)Wyatt Jenkins(Director)

Board seat Maha Ibrahim· per SEC Form D · $18M raise · filed Jun 2018

Genome Medical Holding CoMay 2018SEC filingmedium confidence

HealthtechSouth San Francisco, US

Lisa Alderson(Executive Officer, Director)Randal Scott(Director)Jill Davies(Executive Officer, Director)inElizabeth Moreno(Executive Officer)inMark Sylvester(Executive Officer)Robert Green(Director)

Board seat Stephen Bloch· per SEC Form D · $223.2K raise · filed Aug 2018

Co-investorsEcho Health Ventures Illumina Innovation

Glookoglooko.com in 𝕏Mar 2021

Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring.

Digital HealthHealthtechSaaSPalo Alto, US

Clay Davidson(Executive Officer)inPrakash Menon(Executive Officer)inEd Marshall(Executive Officer)David Pass(Executive Officer)inAdam Hameed(Executive Officer)inMark Beucler(Executive Officer)in

Board seat Wende Hutton· per SEC Form D

Co-investorsHealth Catalyst Capital Samsung Next

Hyalexhyalex.com in 𝕏May 2017

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

Carl Vause(Executive Officer, Director)inMira Sahney(Executive Officer, Director)inDavid Myung(Director)

BoardMichael Hawkins(Director)William Harrington(Director)in

Board seat Wende Hutton· per SEC Form D

Co-investorsOUP (Osage University Partners)Treo Ventures, Llc

JOORjoor.com in 𝕏Jun 2021 · $25M

JOOR is a digital wholesale platform connecting brands and retailers globally for buying and selling fashion products.

B2B MarketplacesE-commerceRetail TechSaaSNew York, US

Kristin Savilia(Executive Officer, Director)in

BoardDan Ciporin(Director)Michael Brown(Director)inEd Neumann(Director)

Board seat Maha Ibrahim· per SEC Form D

Co-investorsAkkadian Ventures Battery Ventures Eastward Capital Partners Great Oaks Venture Capital Multiplier Capital Brightwood Capital Advisors +2 more

Journey Meditationjourneymeditation.com inApr 2025

Journey provides a proactive workplace mental health program designed to identify and address employee mental health risks earlier than traditional employee assistance programs, reducing costs and preventing escalation.

HR TechMental HealthNew York, US

Stephen Sokoler(Executive Officer, Director)in

BoardJoshua Siegel(Director)

Board seat Brendan Dickinson· per SEC Form D

Co-investors37 Angels Betaworks Nelstone Ventures New York Venture Partners BDMI The Fund

Komprisekomprise.com in 𝕏Apr 2015

Komprise provides analytics-driven unstructured data management and mobility software that helps enterprises analyze, tier, and move file and object data across storage systems and the cloud, including curating data for AI.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareCampbell, US

Krishna Subramanian(Executive Officer, Director, Promoter)in Kumar Goswami(Executive Officer, Director, Promoter)inMike Peercy(Founder)in

Board Lip Bu Tan(Director)in

Board seat Maha Ibrahim· per SEC Form D

Co-investorsCelesta Capital Celesta Capital Multiplier Capital

Kustomerkustomer.com in 𝕏Nov 2019

Kustomer is an AI-native customer experience (CX) platform that ties every interaction to a complete customer record so AI and human agents can respond with full context, automate conversations, and manage support workflows.

AI & Machine LearningEnterprise SoftwareSaaSSales TechShort Hills, US

Jeremy Suriel(CTO & Co-Founder)in Brad Birnbaum(CEO & Co-Founder)inMichael Chapin(Executive Officer, Promoter)

BoardScott Beechuk(Director)in Alex Bard(Director)in Neeraj Agrawal(Director)in

Board seat Deepak Kamra· per SEC Form D

Co-investorsAcurio Ventures Battery Ventures boldstart ventures Cisco Investments Coatue Management Norwest Venture Partners +3 more

LyceraJun 2015DefunctSEC filingmedium confidence

Ann Arbor-founded biopharmaceutical company developing small molecule immunomodulators for autoimmune diseases and cancer.

BiotechAnn Arbor, US

Gary Glick(Executive Officer, Director)Paul Sekhri(Executive Officer)Kathleen M. Metters(Executive Officer, Director)

BoardRobert Kamen(Director)inMichael Hayden(Director)Michael Steinmetz(Director)

Board seat Nina Kjellson· per SEC Form D · filed Jun 2015

Co-investorsARCH Venture Partners Clarus Third Rock Ventures

Minimally Invasive DevicesFeb 2015

HealthtechColumbus, US

Wayne Poll(Executive Officer, Director)inRenee Albarano(Executive Officer)Caroline Crisafulli(Executive Officer)

BoardFred M. Schwarzer(Director)

Board seat Wende Hutton Brent Ahrens· per SEC Form D

Myndmynd.co in 𝕏May 2018

Mynd offers full-service property management for single-family rental investors, handling tenant placement, leasing, maintenance, and communications, with a tech-based investor portal for real-time portfolio visibility.

Enterprise SoftwareFintechPropTechSaaSOakland, US

Colin Wiel(Executive Officer, Director)in Doug Brien(Executive Officer, Director)in

Board Richard Boyle(Director)in

Board seat Rich Boyle· per SEC Form D

Co-investorsQED Jackson Square Ventures Lightspeed Venture Partners QED Investors R136 Ventures Thirdstream Partners

Notable FinanceMay 2026SEC filingmedium confidence

Stamford, US

Leigh Stephenson Browne(Executive Officer)Amy Malone(Executive Officer)inRyan Gillette(Executive Officer)Eugene Didenko(Executive Officer)Austin Lane(Executive Officer, Director)

BoardClare Tokheim(Director)

Board seat Laura Chau· per SEC Form D · $2M raise · filed Jul 2026

Co-investorsSecond Century Ventures W. R. Berkley

nTopologyntopology.com in 𝕏Jun 2020 · $65M

nTop (nTopology) makes parametric engineering design software that lets teams generate, explore, and validate complex geometry with manufacturing constraints and embedded FEA/CFD simulation built into the workflow.

Advanced ManufacturingDeep TechEnterprise SoftwareSaaSNew York, US

Gregory Schroy(Executive Officer, Director, Promoter)Bradley Rothenberg(Executive Officer, Director, Promoter)in

Board seat Hrach Simonian· per SEC Form D

Co-investorsCrunchFund Notation Capital Pathbreaker Ventures Root Ventures Manager, Llc Tuesday Capital 1517 +5 more

Olliemyollie.comMar 2024acquired by Agrolimen

Ollie provides personalized fresh dog food recipes crafted by chefs and food scientists, paired with health monitoring services that analyze dog wellness indicators to optimize nutrition and health outcomes for pet owners.

ConsumerFoodTechNew York, US

Nick StaffordinDan Ciporin(Director)Alexandre Douzet(Executive Officer, Director)Steve Marton(Director)

BoardBenjamin Sun(Director)

Board seat Laura Chau· per SEC Form D

Co-investorsARC Angel Fund Correlation Ventures Darco Capital Felicis Ventures Interplay Ventures Early Stage Management Llc Lerer Hippeau +3 more

OncoResponseoncoresponseinc.comApr 2025 · $14M

Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.

BiotechHouston, US

Alice Bexon(Executive Officer)inClifford J. Stocks(Director, Executive Officer)inKamal D. Puri(Executive Officer)inChris Russell(Executive Officer)inRuss Hawkinson(Executive Officer)

Board Steven Gillis(Director)in

Board seat Wende Hutton· per SEC Form D

Co-investors3B Future Health Fund GreatPoint Ventures RiverVest Venture Partners ARCH Venture Partners Bering Capital Intervest +3 more

Onkos Surgicalonkossurgical.com in 𝕏Apr 2017

Onkos Surgical develops limb salvage and orthopedic reconstruction implants and systems for treating musculoskeletal cancer and complex orthopedic conditions.

HardwareHealthtechMedical DevicesParsippany, US

Patrick Treacy(Founder)inAntony Koblish(Director, Promoter)inBrad Tyler(Executive Officer)in

BoardAdele Oliva(Director)Paul Touhey(Director)

Board seat Stephen Bloch· per SEC Form D

Co-investors1315 Capital JSD Capital, LLC SV Health Investors

Portal Space Systemsportalsystems.spaceMar 2026SEC filingmedium confidence

Portal Space Systems develops advanced spacecraft, including its flagship Supernova vehicle, designed for high delta-v maneuverability and multi-orbit operations in cislunar space.

Deep TechHardwareSpace TechWashington, US

Jeffery Thornburg(Executive Officer, Director, Promoter)Ian Vorbach(Director)inPrashaanth Ravindran(Director)in

Board seat Rayfe Gaspar-Asaoka· per SEC Form D · $72.4M raise · filed Mar 2026

Co-investorsAlleyCorp Booz Allen Ventures FUSE Geodesic Capital IceNine TFX Capital +5 more

Qlaris Bioqlaris.bio inJun 2026

Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.

BiotechMedical DevicesDedham, US

Thurein Htoo(Executive Officer, Director)inFred Guerard(President & Chief Executive Officer)inBarbara Wirostko(Executive Officer)

BoardRonald M. Hunt(Director)Andrew Danielson(Director)

Board seat Wende Hutton· per SEC Form D

Co-investorsabrdn plc Correlation Ventures Mayo Clinic Ventures New Leaf Venture Partners

Quantum Circuitsquantumcircuits.com inFeb 2024Acquired

Quantum Circuits develops superconducting quantum computers using dual-rail qubits with built-in error detection, designed to accelerate the path to fault-tolerant quantum computing.

Advanced ManufacturingDeep TechHardwareQuantum ComputingMadison, US

Rob Schoelkopf(Sterling Professor, Founder)inLuigi FrunzioRay Smetsin

Board seat Brendan Dickinson· per SEC Form D

Co-investorsARCH Venture Partners Connecticut Innovations F-Prime Capital Fitz Gate Ventures OUP (Osage University Partners)Tribeca Venture Partners

Realty Mogulrealtymogul.com in 𝕏Jul 2015

RealtyMogul is a real estate crowdfunding platform that enables investors to access commercial real estate investment opportunities.

B2B MarketplacesFintechMarketplacesPropTechLos Angeles, US

Jilliene Helman(Executive Officer, Director, Promoter)inJustin Hughes(Director)

BoardSteve Ozonian(Director)

Board seat Hrach Simonian· per SEC Form D

Co-investorsMDT Ventures Techstars VoiVoda Ventures

Reischling PressJul 2020SEC filingmedium confidence

Tukwila, US

Richard Bellamy(Executive Officer, Director)

BoardBill Heston(Director)Tim Bubnack(Director)Victor Petroff(Director)

Board seat John Balen· per SEC Form D · $7.4M raise · filed Aug 2020

RelayRides inAug 2015

San Francisco, US

Shelby Clark(Director)inAndre Haddad(Executive Officer, Director)Anne Dorman(Executive Officer)in

Board Howard Hartenbaum(Director)inJoe Kraus(Director)

Board seat Deepak Kamra· per SEC Form D

Co-investorsAugust Capital GV (Google Ventures)Shasta Ventures Spero Ventures

Relievant Medsystemsrelievant.comFeb 2015

Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.

Medical DevicesRedwood City, US

Alex DiNello(Executive Officer, Director)

BoardRichard Mott(Director)Justin Klein(Director)inJason Lettman(Director)John Ryan(Director)

Board seat Brent Ahrens· per SEC Form D

Co-investorsEmergent Medical Partners, LLP Lightstone Ventures New Enterprise Associates (NEA)Vensana Capital

Renofirenofi.com in 𝕏Dec 2024

RenoFi is a fintech platform that enables credit unions to offer home equity loans and HELOCs based on after-renovation property values to homeowners financing renovation and construction projects.

FintechPropTechPhiladelphia, US

Justin Goldman(Co-Founder & CEO)in Robert Shedd(Executive Officer, Director)inLee Miller(Executive Officer, Director)in

BoardSamanttabhiram Das(Director)

Board seat Brendan Dickinson· per SEC Form D

Co-investorsComcast Ventures Curql Collective, LLC Next Level Ventures Nyca Nyca Partners TruStage Ventures +1 more

Revision OpticsOct 2016SEC filingmedium confidence

Lake Forest, US

John T. Kilcoyne(Executive Officer, Director)Louis Bunn(Executive Officer)

BoardRenee Ryan(Director)Gilbert H. Kliman(Director)Inna Martin Eitan(Director)

Board seat Wende Hutton· per SEC Form D · $45M raise · filed Nov 2016

Co-investorsDomain Partners

Safire Technology Group, Inc.inDec 2025

Tysons, US

JOHN LEE(Executive Officer, Director)inMICHAEL GRUBBS(Executive Officer, Director)

Board seat Hrach Simonian· per SEC Form D

Co-investorsAJINOMOTO CO.,INC.Automotive Ventures Correlation Ventures MaC Venture Capital OUTPOST VENTURES

SOASTAsoasta.comAug 2015

Mountain View, US

Thomas Lounibos(Executive Officer, Director)Peter Boyes(Executive Officer)Gamiel Gran(Executive Officer)

BoardClint Chao(Director)Blake Modersitzki(Director)

Board seat John Balen· per SEC Form D

Co-investorsMacquarie Capital Pelion Venture Partners

Solstice OncologyFeb 2026SEC filingmedium confidence

BiotechBoston, US

David Feltquate(Executive Officer)Maiken Keson-Brookes(Executive Officer)CAROLINE LOEW(Executive Officer, Director, Promoter)

Board ANDREW LEVIN(Director)EMILY MINKOW(Director)in

Board seatJulie Grant· per SEC Form D · $298.4M raise · filed Mar 2026

Co-investorsForbion RA Capital

Sounding Boardsoundingboardinc.com in 𝕏Dec 2020Acquired

Sounding Board provides leadership development and coaching programs delivered through software, combining a global network of expert coaches with tools to build, manage, track, and measure development initiatives.

Future of WorkHR TechSaaSAliso Viejo, US

Lori Mazan(Co-founder & Chief Coaching Officer)in Christine Tao(Co-Founder & CEO)in

Board seat Maha Ibrahim· per SEC Form D

Co-investorsJAZZ Venture Partners Tech Square Ventures Bloomberg Beta

Spyryx Biosciences inJun 2017

BiotechResearch Triangle Park, US

Andrew Jordan(Executive Officer, Director)John Taylor(Executive Officer, Director, Promoter)Robert Tarran(Director)

BoardDonald Rose(Director)

Board seat Tim Shannon· per SEC Form D

Co-investors5AM Ventures Hatteras Venture Partners

Stargazer PharmaceuticalsApr 2018 · $57M

BiotechBoston, US

Gary Sternberg(Executive Officer, Director)

BoardIyona Rajkomar(Director)inRichard Gaster(Director)Nanna Luneborg(Director)Daniel Curran(Director)

Board seat Wende Hutton· per SEC Form D

Co-investorsPontifax Venture Capital Novo Holdings venBio Partners

TAPTAPtaptapsend.com in 𝕏May 2020

Taptap Send is a money transfer application that enables users to send remittances to over 70 destinations across Africa, Asia, the Caribbean, and Latin America at lower costs and faster speeds than traditional services.

FintechImpact & Social GoodNew York, GB

Michael Faye(Executive Officer, Director, Promoter)inMitchell Riley(Executive Officer)

BoardChristopher Schroeder(Director)

Board seat Brendan Dickinson· per SEC Form D

Co-investorsOmidyar Network Balderton Capital Blue Collective Breyer Capital Finberg Formus Capital +5 more

The Real Real x-tech-roboticstherealreal.com in 𝕏Mar 2015

The RealReal is an online marketplace for authenticated luxury consignment, allowing consumers to buy and sell pre-owned designer clothing, accessories, jewelry, watches, and home goods.

Circular EconomyConsumerE-commerceMarketplacesSan Francisco, US

Julie Wainwright(Executive Officer, Director)Matt Gustke(Executive Officer)inHenry V. Barry(Executive Officer)

Board Mathias Schilling(Director)inCynthia Ringo(Director)Keval Desai(Director)in

Board seat Maha Ibrahim· per SEC Form D

Co-investorsAcrew Capital Aspect Ventures Bright Pixel Capital DBL Partners Expansion Venture Capital Greycroft +11 more

Theraclone SciencesApr 2015SEC filingmedium confidence

BiotechSeattle, US

Kristine Swiderek(Executive Officer)Russ Hawkinson(Executive Officer)Clifford Stocks(Executive Officer, Director)

BoardSteven Gillis(Executive Officer, Director)Christopher Mirabelli(Director)

Board seat Wende Hutton· per SEC Form D · $4.4M raise · filed May 2015

Transcend MedicalMar 2014acquired by Alcon · Feb 2016 · $332M

Transcend Medical was a Menlo Park, CA medical-device company spun out of ForSight Labs that developed the CyPass Micro-Stent, a minimally invasive glaucoma implant to reduce intraocular pressure.

Menlo Park, US

Board seat Wende Hutton· per SEC Form D

Co-investorsLightstone Ventures

Transposon Therapeuticstransposonrx.comApr 2020

Transposon Therapeutics is a biotechnology company developing therapies for neurodegenerative and aging-related diseases, with a pipeline that includes its lead candidate TPN-101 and novel NRTIs targeting conditions such as PSP, ALS/FTD, and Alzheimer's disease.

BiotechHealthtechLongevitySan Diego, US

Dennis Podlesak(Executive Officer, Director)Lynne R. Rollins(Executive Officer)Eckard Weber, MD(Executive Officer, Director)Eckard Weber, M.D.(Executive Officer, Director)in

BoardDaniel Hetu, MD, MBA(Director)

Board seat Brent Ahrens John Pacifico· per SEC Form D

Truveristruveris.com in 𝕏Aug 2017 · $15M

Truveris offers a technology platform with claims analytics and PBM (pharmacy benefit manager) oversight to reduce pharmacy benefit costs through contract optimization for employers.

Data & InfrastructureDigital HealthHealthtechSaaSNew York, US

Anthony Joseph Loiacono(Executive Vice-President, Sales and Marketing)Michael Facendola(Executive Officer)inLouise Shea(Chief Pharmacy Officer)in Bryan Birch(Chief Executive Officer)in

BoardPhilippe Chambon(Director)Stephen M. Bloch(Director)in

Board seat Stephen Bloch· per SEC Form D

Co-investorsMcKesson Ventures NAV.VC Tribeca Venture Partners New Leaf Venture Partners

Unchained Labsunchainedlabs.com in 𝕏Feb 2015

Unchained Labs builds instruments for lipid nanoparticle and other nanomedicine production, spanning R&D formulation screening through GMP-compliant clinical manufacturing.

AI & Machine LearningBiotechHardwareHealthtechPleasanton, US

Tim Harkness(Executive Officer, Director)inJason Novi(Executive Officer)in

BoardHeather Preston(Director)Jack Nielsen(Director)Joe Keegan(Director)

Board seat Brent Ahrens· per SEC Form D

Co-investorsCEI Ventures Tri-Valley Ventures TPG

Unifi Software inOct 2015

San Mateo, US

Ayush Parashar(Executive Officer)inJames Carr(Executive Officer)Sean Keenan(Executive Officer)inRobert Carlson(Executive Officer, Director)

BoardRoseanne Wincek(Director)Mike Asher(Director)

Board seat Maha Ibrahim· per SEC Form D

Co-investorsBlue Cloud Ventures Renegade Partners Scale Venture Partners

UrbanSitterurbansitter.com in 𝕏Apr 2025

UrbanSitter operates a marketplace platform where families book childcare, tutoring, pet sitting, housekeeping, and senior care services, while caregivers access flexible job opportunities with transparent pay and client reviews.

ConsumerFuture of WorkMarketplacesSan Francisco, US

Lynn Perkins(Co-founder)inAndrea Barrett(Co-founder)inJessica Steel(Executive Officer, Director)in

Board Vincent Caruso(Director)in David ibnAle(Director)in

Board seat John Balen· per SEC Form D

Co-investorsAdvance Venture Partners Aspect Ventures DBL Partners Owl Capital Royal Street Ventures Management Company, Llc The Perkins Fund +1 more

Virgin Pulsevirginpulse.comAug 2015SEC filingmedium confidence

Denver, US

Board seat Nina Kjellson· per SEC Form D · $45M raise · filed Dec 2015

Co-investorsBessemer Venture Partners Excel Venture Management Insight Partners Marlin Equity Partners New Enterprise Associates (NEA)

Vitruvian NetworksApr 2018SEC filingmedium confidence

BiotechSan Francisco, US

Amy Duross(Executive Officer)Jason Bowman(Executive Officer)

BoardNigel Darby(Director)Rowan Chapman(Director)

Board seat Nina Kjellson· per SEC Form D · $33.5M raise · filed Apr 2018

Co-investorsCasdin Capital Threshold Ventures

World View Enterprisesworldview.space in 𝕏Feb 2016SEC filingmedium confidence

Worldview provides high-altitude balloon remote sensing and persistent stratospheric observation, integrating sensors and platforms across air, stratosphere, and space into a unified intelligence workflow.

AI & Machine LearningDefense TechSpace TechTravel & HospitalityTucson, US

Taber MacCallum(Executive Officer, Director, Promoter)inJane Poynter(Executive Officer, Director, Promoter)inGrant Anderson(Executive Officer, Director)in Alan Stern(Director)inStephen Wideman(Executive Officer)inRyan Hartman(Executive Officer, Director)in

Board seat Deepak Kamra· per SEC Form D · $15.1M raise · filed May 2016

Co-investorsAccel Base Venture Management, Inc.Breakthrough Victoria Norwest Venture Partners Western Technology Investment NEW VISTA CAPITAL

Abyrxabyrx.com in 𝕏

ABYRX develops synthetic, absorbable surgical biomaterials, including a bone hemostat used to stop bleeding on bone surfaces during surgery.

BiotechHealthtechMedical DevicesNew MaterialsStamford, US

Aceissaceiss.com

Aceiss detects unauthorized employee access to company systems and monitors user privileges across applications to prevent cyber attacks.

CybersecurityDeveloper ToolsEnterprise Software

Co-investorsConnecticut Innovations Insight Partners

Actio Biosciences, Inc.actiobiosciences.com in 𝕏

Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions.

BiotechDeep Tech

David Breckenridge(Founder)in

Co-investorsEcoR1 Capital

ACTIVE Networkactivenetwork.com in

ACTIVE Network builds event and activity management software for race organizers, camps, sports teams, resorts, and public sector organizations, offering online registration, payment processing, timing, scheduling, and participant engagement tools.

Enterprise SoftwareGovTechSaaSSports TechDallas, US

Co-investorsVista Equity Partners Escalate Capital Partners Moonshots Capital Sierra Ventures

ActualyzeAI, Inc.actualyze.ai in 𝕏

Actualyze.ai offers a governed control plane for enterprise AI, giving teams self-serve access to vetted models and agents while the platform handles access, cost, routing, and guardrails.

AI & Machine LearningCybersecurityDeveloper ToolsEnterprise Software

Rafi Khardalian(Co-founder)inSean(Co-founder & CTO)in

Advanced BioHealingacquired by Shire · May 2011 · $750M

Advanced BioHealing was a regenerative medicine company that commercialized cell-based and tissue-engineered products, notably Dermagraft, a dermal substitute for diabetic foot ulcers.

Agomab Therapeuticsagomab.com in

Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.

BiotechHealthtechMedical DevicesAntwerp, BE

Tim Knotnerus(Chief Executive Officer)in

Co-investorsEQT Life Sciences AdBio partners Andera Partners Asabys Partners Pontifax Venture Capital V-Bio Ventures +1 more

Aim Securityaim.security in 𝕏Jun 2024 · $18Macquired by Cato Networks

Aim Security developed an enterprise AI security platform to secure the adoption and use of generative AI, protecting against risks such as data leakage and prompt-based attacks.

Cloud ComputingCybersecurityEnterprise Software

Matan G.‏(Founder)in

Co-investorsYL Ventures

AirEyeaireye.tech in 𝕏Apr 2021

AirEye develops a wireless airspace security platform that provides visibility, classification, monitoring, and Layer 2 firewall protection against threats such as rogue access points, evil twins, and unauthorized network access.

AI & Machine LearningCybersecurityEnterprise SoftwareIoTSaaS

Tanuj Mohan(Founder)in Ori Calvo(Co-founder)in

Co-investorsU.S. Venture Partners

Alkymialkymi.io in 𝕏

Alkymi provides an AI-powered platform that extracts and automates data from unstructured documents, turning it into workflow-ready data via APIs.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechNew York City, US

Co-investorsWork-Bench Intel Capital Essence Venture Capital

Alsius Corporationacquired by ZOLL Medical Corporation · May 2009 · $12M

Alsius Corporation made catheter-based intravascular temperature management devices used to induce therapeutic hypothermia in patients with cardiac arrest or brain injury.

AlterEgo Networks

Alterome Therapeutics, Inc.alterome.com inDec 2021

Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic.

AI & Machine LearningBiotechDeep TechSan Diego, US

Eric A. Murphy(Executive Officer, Director, Promoter)inRyan B. Corcoran(Director, Promoter)

Board Thilo Schroeder(Director)in Carl Gordon(Director)in Arjun Goyal(Director)in

Co-investorsNextech Invest OrbiMed Vida Ventures Digitalis Ventures NVIDIA

Altimate Incaltimate.ai in 𝕏Sep 2022

Altimate provides an open-source, tech-stack-agnostic agentic data platform whose AI data agents automate tasks such as building data pipelines, migrating workloads, managing infrastructure, and enforcing data governance.

AI & Machine LearningData & InfrastructureDeveloper ToolsSunnyvale, US

Anand Gupta(Executive Officer, Director)in Pradnesh Patil(Executive Officer, Director)inAtul Pawar(Director)

Co-investorsSierra Ventures

Ambra Healthambrahealth.com in 𝕏

Ambra Health provides a cloud-based medical imaging suite that connects physicians and care staff to imaging information across the patient journey.

Cloud ComputingDigital HealthHealthtechMedical Devices

Amicus Therapeuticsamicusrx.com in

Amicus is a rare disease biotechnology company developing medicines for people with genetically defined conditions.

BiotechHealthtechCranbury, US

Daphne Quimi(Executive Officer)John Crowley(Executive Officer, Director)William D. Baird, III(Executive Officer)

BoardCraig A. Wheeler(Director)Ted W. Love(Director)Margaret G. McGlynn(Director)

Co-investorsAvoro Capital Advisors Frazier Life Sciences New Enterprise Associates (NEA)Prospect Venture Partners

Apartment Listapartmentlist.com in 𝕏Dec 2014

Apartment List operates an online rental marketplace that uses a quiz-based AI matching system to connect renters with apartments that fit their preferences and lifestyle.

AI & Machine LearningMarketplacesPropTechSan Francisco, US

John Douglas Kobs II(Executive Officer, Director)Charles Christopher Herndon(Executive Officer, Director)John Kobs(Founder)in Chris Erickson(Co-founder)in

BoardJosh Hannah(Director)Dana Stalder(Director)in

Co-investorsAndre Iguodala AUTHENTIC VENTURES Glynn Capital Management Matrix Tenaya Capital Tribeca Early Stage Partners +3 more

Apieronacquired by Aerocrine · May 2010

Apieron was a Menlo Park medical device company that developed the FDA-cleared Insight eNO System, a device measuring exhaled nitric oxide to help manage asthma-related airway inflammation.

APIsec

Appsmithappsmith.com in 𝕏

Appsmith provides an open-source platform that enables developers to build internal applications like admin panels and dashboards more efficiently.

Developer ToolsEnterprise SoftwareSaaS

Abhishek Arpit Mohan(Founder)in Nikhil Nandagopal(Founder)in

Co-investorsAccel Bessemer Venture Partners Insight Partners

Arbor Networksacquired by NetScout Systems · Jul 2015

Arbor Networks made network security and monitoring software, including its Peakflow/ATLAS platform, used by ISPs and enterprises to detect and mitigate DDoS attacks.

Co-investorsLightspeed Venture Partners

Arcadearcade.ai

Sam Partee(Founder)in

Co-investorsAdverb Ventures Factorial Funds Inspired Capital Torch Capital Sound Ventures

Archipelagoonarchipelago.com in 𝕏Apr 2021 · $34M

Archipelago operates a data network for insurance brokers and their commercial property customers, connecting brokers, owners, insurers, and service providers to replace spreadsheet-based processes with more accurate property risk data.

AI & Machine LearningData & InfrastructureInsurTechSaaSSan Francisco, US

Hemant Shah(Founder)inRoger Bodamer(Chief Technical Officer and Operating Officer)in

Co-investorsScale Venture Partners Thompson Hutton, LLC Zigg Capital Prologis Ventures Stone Point

Argon Networksacquired by Siemens · Mar 1999 · $200M

Argon Networks was a late-1990s startup that developed a high-speed, carrier-grade gigabit switch-router for next-generation Internet and data service providers, combining wire-speed IP routing with ATM switching.

Artieartie.com in 𝕏Nov 2025

Artie provides a data replication platform built on change data capture (CDC) technology, enabling real-time data movement with sub-minute latency and zero data loss.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Jacqueline Cheong(Founder)in Robin Tang(Founder)inArmando McIntyre-Kirwin(Executive Officer, Director)Ryan Horrigan(Executive Officer, Director)

Co-investorsStandard Capital Calano Ventures FJ Labs General Catalyst IA Seed Ventures Pathlight Ventures +6 more

Ascendifyascendify.com in 𝕏May 2017

Radancy offers an AI-powered CRM platform for recruiting teams that consolidates candidate data from multiple sources, automates matching and outreach, and provides analytics to optimize hiring workflows.

AI & Machine LearningHR TechSaaSSan Francisco, US

Lauren Smith(Executive Officer, Director)inMatt Hendrickson(Executive Officer, Director)in

BoardTom Spengler(Director)Richard Natsch(Director)

Co-investorsBlossom Street Ventures Cisco Investments GE Ventures

Assisassis.co inApr 2023 · $5M

Assis is an AI-powered agent platform that automates customer interactions and sales processes, qualifying leads, handling follow-ups, and conducting outreach across various customer lifecycle stages with integration into existing business systems.

AI & Machine LearningSaaSSales TechSão Paulo, BR

João Eduardo Bergamo(Founder)in

Co-investorsFJ Labs Latitud Ventures Norte Ventures Costanoa Ventures K50 Ventures MAYA Capital +1 more

Associated Contentacquired by Yahoo · May 2010 · $90M

Associated Content was a crowdsourced online publishing platform founded in 2005 that paid freelance contributors to create articles, videos, and other content monetized via advertising and syndication.

Astraastra.com in

Astra provides dedicated orbital launch services and manufactures electric propulsion systems for satellites.

Defense TechHardwareSpace TechAlameda, US

Chris Kemp(Founder)inDr. Adam London(Founder)

Co-investorsACME Capital Bay Bridge Ventures Climate Chenel Capital Partners Evolution VC Partners Helios Capital PROOF +4 more

AtheroMedMar 2012acquired by Volcano Corporation · Jun 2014 · $130M

AtheroMed was a Menlo Park medical device company that developed the Phoenix Atherectomy System, a catheter-based device to mechanically remove arterial plaque in peripheral artery disease patients.

HealthtechMenlo Park, US

Chris Danek(Executive Officer)Will McGuire(Executive Officer, Director)

BoardDavid Schulte(Director)Casey Tansey(Director)Alan Kaganov(Director)Tony Chou(Director)

Co-investorsKaiser Permanente Ventures US Venture Partners

Atmosfyatmosfy.io inOct 2023 · $12M

Atmosfy provides real-time video coverage and data infrastructure for understanding physical-world activity, enabling businesses to access live local context for consumer engagement, model training, and real-world intelligence applications.

AdTechData & InfrastructureSan Francisco, US

Michael Ebel(Founder)in

Co-investorsPalm Tree Crew Investments Redpoint Ventures Streamlined Ventures Industry Ventures Progression Village Global

Autobahn Therapeutics, Inc.autobahntx.com inJun 2024

Autobahn Therapeutics develops orally administered small molecule prodrugs using a brain-targeting chemistry platform to create regenerative medicines for central nervous system (CNS) disorders.

BiotechDeep TechMedical DevicesSan Diego, US

Kevin Finney(Chairman, President and CEO)inJohn Borkholder(Executive Officer)in

Board Kristina Burow(Director)in Thomas Cahill(Director)Timothy Anderson(Director)Philip J DeSouza(Director)

Co-investorsARCH Venture Partners Monograph Capital Partners Pfizer Venture Investments Samsara BioCapital Newpath Partners

Axcelius I/II

Axis Securityaxissecurity.comAcquired

Zero trust network access vendor whose cloud-based secure access platform was acquired by HPE in 2023.

Co-investorsCyberstarts Emerald Development Managers Ten Eleven Spark Capital

Aziboazibo.com in 𝕏Dec 2021

Azibo is a property management platform that enables landlords to collect rent, screen tenants, manage leases, track maintenance, and handle accounting and tax preparation.

FintechPropTechSaaSReno, US

Christopher Hsu(Executive Officer, Director)

Board David Weiden(Director)inGregor Watson(Director)Richard Boyle(Director)inSarah Dickens Spoja(Director)

Co-investorsCamber Creek RET Ventures Assurant Ventures Context Ventures Gaingels Khosla Ventures +3 more

Basebuild, Inc.basebuild.com in 𝕏

Beams is an AI project management tool that transcribes desktop meetings and automatically tracks decisions, action items, and project risks, turning discussions and project data into a searchable knowledge base.

AI & Machine LearningConstruction TechSaaS

Co-investorsRWT Horizons

Beckonbeckon.com in 𝕏acquired by IgniteTech

AI & Machine LearningEnterprise SoftwareSaaSSan Mateo, US

Jennifer Zeszut(Executive Officer, Director)Eric Vaughan(CEO)inJochen Frey(Executive Officer, Director)

BoardRoss Fubini(Director)Brian Ascher(Director)in Howard Hartenbaum(Director)in

Co-investorsAugust Capital Rally Ventures Management, Llc Venrock

Bellhops Software falsegetbellhops.com in 𝕏

Bellhop is a moving company offering local and long-distance residential moves, with services including loading, unloading, delivery, and hourly labor booked through its app or website.

ConsumerLogistics & Supply ChainMarketplacesMobility & Transportation

Co-investorsAdvance Venture Partners Great Oaks Venture Capital Lerer Hippeau Lowercase Capital

Benefit SolutionsMay 2024 · $15M

HealthtechMukilteo, US

Douglas P. Gorder(Executive Officer)Shannon Jurdana(Executive Officer, Director)

Co-investorsNew Leaf Venture Partners Novacap TA Associates

Berkshire Greyberkshiregrey.com in

Berkshire Grey builds robotics, machine vision, and control software for warehouse and distribution operations, automating tasks such as trailer unloading, picking, sorting, and outbound shipment preparation.

AI & Machine LearningLogistics & Supply ChainRobotics

Tom Wagner, Ph.D.(Founder)inDavid Paratore(CEO)inMark Fidler(CFO)inPeter Van Alstine(Chief Commercial Officer)inEllen Bossert(Senior Vice President of Strategy)inBrad Meyer(Vice President, Customer Experience)in

Co-investorsNew Enterprise Associates (NEA)Perot Jain SoftBank Vision Fund

Bevdrinkbev.com

Bev is a beverage brand that makes canned drinks with less than 1g of sugar, positioned around a women-led community and lifestyle.

ConsumerDirect to ConsumerFoodTech

Alix Peabody(Founder)in

Co-investorsMaC Venture Capital Founders Fund

Bharat Matrimonybharatmatrimony.in

Murugavel Janakiraman(Founder)in

Co-investorsBessemer Venture Partners

Binarlybinarly.io in 𝕏

Santa Monica, US

Alex Matrosov(Founder)

Co-investorsStoneMill Ventures Two Bear Capital

BiPar Sciencessanofi.usAcquired

Biopharmaceutical developer of tumor-selective PARP inhibitor cancer therapies, acquired by Sanofi-aventis in 2009.

Co-investorsAisling Capital Asset Management Company Kleiner Perkins SPRINGROCK VENTURES VantagePoint Capital Partners Domain Associates

Bird Scootersbird.co in

Bird operates a shared electric scooter and e-bike service designed to reduce car trips and emissions in urban environments across multiple continents.

CleantechMobility & TransportationSanta Monica, US

Co-investorsAccel Alate Partners CoastCap Comcast Ventures Craft Ventures CRV (Charles River Ventures)+19 more

Blurbblurb.com 𝕏Sep 2010

Blurb is a self-publishing and print-on-demand platform that lets authors and creators design, format, print, and distribute their own books, including photo books, memoirs, and other titles.

ConsumerCreator EconomyE-commerceMedia & EntertainmentSaaSSan Francisco, US

Eileen Gittins(Founder & CEO (later Executive Chairman))Andrew Wait(Executive Officer)Pete Wheelan(Executive Officer)Mark Lambert(Executive Officer)Todd Larsen(Chief Executive Officer)

BoardBrian Mesic(Director)

Bondbond.tech in 𝕏Acquired

Bond offers an embedded finance platform with modern APIs and program management support that lets companies build, launch, and operate their own financial products for their customers.

Developer ToolsEnterprise SoftwareFintechSaaS

Roy Ng(Co-founder & CEO)in

Co-investorsCoatue Management XYZ Venture Capital

Borroborro.one in

Borro provides a reusable cup system for large venues such as sports stadiums, aiming to make cup reuse fast and reliable.

Circular EconomySports Tech

Kasper Albers(Founder)in

Co-investorsSeeder Fund Augmentum Capital OurCrowd Ribbit Capital Rocket Internet SE

Bravo Sierrabravosierra.com in

Bravo Sierra makes personal care products, including a sulfate-free body wash with a coconut-derived cleanser, natural oils, and Squalane for hydration and skin barrier protection.

ConsumerDirect to ConsumerE-commerceWellness & FitnessNew York City, US

Benjamin Bernet(Founder)in

Co-investorsGrace Beauty Capital REDO Ventures AF Ventures BoxGroup Capstar Ventures Global Founders Capital

Brigithellobrigit.com in 𝕏Acquired

Brigit is a mobile financial health app that helps low-income Americans avoid overdrafts, access emergency cash, build credit, and budget for savings.

Fintech

Zuben Mathews(Co-founder)inHamel Kothari(Co-founder)in

Co-investorsAbstract Ventures Core Venture Capital DCM Ventures DN Capital Dreamers VC Hummingbird Ventures +11 more

Bumblebeebumblebeespaces.com in

Robotics furniture startup designed to change the way of living.

Co-investorsLoup Ventures UpHonest Capital VU Venture Partners Bloomberg Beta IIMA Ventures Inertia Ventures +3 more

Bumpedbumped.com

Portland, US

DAVID A. NELSEN(Executive Officer, Director)

Co-investorsElevate Capital Commerce Ventures Oregon Venture Fund

Buzzerbuzzer.com

Bzaarbzaar.comDec 2021

Grosse Pointe Woods, US

Prasanth Narayanan Nair(Executive Officer, Director)Joydeep Bhattacharya(Director)

BoardNishant Verman(Executive Officer, Director)

C Infinityc-infinity.ai in

C-Infinity builds foundational AI for mechanical design and manufacturing that reasons about 3D geometry, motion, spatial constraints, and production logic.

Advanced ManufacturingAI & Machine LearningDeep TechMountain View, US

Johan de Kleer(Founder)in

Co-investorsInventus Capital Partners Radius Capital Ventures

Calibra Medicalacquired by Johnson & Johnson · Jul 2012 · $77M

Calibra Medical was a Redwood City, CA medical device company that developed the Finesse, a small mechanical insulin patch-pen for delivering bolus doses to diabetics.

Calixa Therapeuticsacquired by Cubist Pharmaceuticals, Inc. · Dec 2009 · $92.5M

Calixa Therapeutics was a San Diego biopharmaceutical company developing intravenous antibiotics, including CXA-101/CXA-201, to treat multi-drug-resistant Gram-negative bacterial infections in hospitals.

Canaan Partners Israelcanaanil.com

Canaan Partners Israel (CPI) is a venture capital fund investing in seed and early-stage technology startups in Israel, focused on digital life and mobile, AI and enterprise solutions, and internet and cloud infrastructure.

Canopy Technology Corpcanopyservicing.com in 𝕏

Canopy provides an event-driven, immutable lending core that companies use as a system of record or integration layer to build and manage business lending products.

Enterprise SoftwareFintechSaaS

Co-investorsCommerce Ventures Homebrew Infinity Ventures Western Technology Investment

Capella Spacecapellaspace.com in 𝕏Acquired

Capella Space designs, builds, and operates synthetic aperture radar (SAR) satellite constellations that provide all-weather, day-and-night Earth observation imagery at sub-0.25m resolution.

Deep TechDefense TechHardwareMedia & EntertainmentSpace TechPalo Alto, US

Payam Banazadeh(Executive Officer, Director)in

BoardWilliam Woods(Director)Chris Boshuizen(Director)in Nabeel Hyatt(Director)in

Co-investorsAME Cloud Ventures Blue Ivy Ventures Castor Ventures (an Alumni Ventures Fund)Cota Capital Dorm Room Harmony Partners +7 more

CAPMAC Holdingsacquired by MBIA Inc. · Feb 1998 · $558.1M

CapMAC Holdings was a New York-based financial guaranty insurance holding company providing financial guarantee insurance for structured securities and municipal bonds.

Capstone Turbine Corporationcapstoneturbine.com

CatalYmcatalym.com in

CatalYm develops immunotherapies for solid tumors by neutralizing GDF-15, a factor cancer cells use to suppress immune responses and resist treatment.

BiotechDeep TechHealthtechMunich, DE

Jörg Wischhusen(Scientific Co-founder)Scott Clarke(Chief Executive Officer)inPeter Garcia(Chief Financial Officer)Sujata Rao(Chief Medical Officer)inStefan Ries(Chief Scientific Officer and Head of Munich Site)inAndrea Goddard(Chief Technical Officer)in

Co-investorsJeito Capital Bioqube Ventures Forbion Bayern Kapital Novartis Venture Fund BioGeneration Ventures +1 more

Cayena Holdings Limitedcayena.com in

Company Picus backed from its earliest steps.

Madrid, ES

Raymond Shayo(Founder)inES Raymond Shayo(Founder)Gabriel Sendacz(Co-Founder)inPedro Carvalho(Co-Founder & CEO)

Co-investorsAstella Clocktower Ventures FEMSA Ventures MSA Novo Norte Ventures PICUS CAPITAL +2 more

Cell Pathwaysacquired by OSI Pharmaceuticals, Inc. · Jun 2003 · $32M

Cell Pathways was a Horsham, Pennsylvania biopharmaceutical company developing apoptosis-inducing small-molecule drugs, including exisulind and CP461, to treat and prevent colon and lung cancer.

Cellular Researchacquired by Becton, Dickinson and Company (BD) · Aug 2015

Cellular Research developed proprietary Molecular Indexing technology enabling massively parallel single-cell gene-expression analysis for genomics research.

Cerexaacquired by Forest Laboratories · Dec 2006 · $493.6M

Cerexa was a biopharmaceutical company developing anti-infective therapies, including the cephalosporin antibiotic ceftaroline and carbapenem ME1036.

Co-investorsFrazier Life Sciences

Chimerix NASDAQ: CMRX www.chimerix.comchimerix.com in 𝕏Jul 2019

Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.

BiotechHealthtechMedical DevicesDurham, US

Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)

Co-investorsAisling Capital Alta Partners Asset Management Company Frazier Life Sciences Pappas Capital Sanderling Ventures

CircleUpcircleup.comMay 2025

Beaverton, US

Eric Gregg(Executive Officer, Director)Nathan Goff(Executive Officer, Director, Promoter)Aaron Green(Executive Officer, Director)

Co-investorsClocktower Ventures Evolution VC Partners Sozo Ventures Union Square Ventures (USV)QED Investors

Civitas Therapeuticscivitastherapeutics.comAug 2014

BiotechChelsea, US

RICHARD BATYCKY(Executive Officer)GLENN BATCHELDER(Director)BRYAN STUART(Executive Officer)MARK IWICKI(Executive Officer, Director)inMARTIN FREED(Executive Officer)in

BoardROB HOPFNER(Director)

Co-investorsSofinnova Ventures Bay City Capital Longitude Capital OrbiMed RA Capital

Climacell

Co-investorsPrelude Ventures

Cloud CaptainJul 2025

San Francisco, US

Anish Doshi(Executive Officer, Director)Zachary Max Witzel(Executive Officer, Director)

BoardShishir Jakati(Director)

Coinminecoinmine.com

Coinmine makes the Coinmine One, a plug-and-play consumer device for mining and earning cryptocurrency at home.

Co-investorsCoinbase Ventures Oyster Ventures M13 M13 Ventures

CombinatoRxacquired by Horizon Discovery Group plc · May 2014 · $8M

CombinatoRx was a Boston-based biotech that screened combinations of already-FDA-approved drugs to discover new synergistic drug therapies.

Commerce OneAcquired

Described as the world's first e-commerce platform.

Co-investorsRho Capital Partners Rho Ventures WI Harper Group

Commonwealthcommonwealth.im

Commonwealth (commonwealth.im) is a DAO coordination platform; the sources supplied contain no verifiable information about it.

Co-investorsCoinbase Ventures IOSG Ventures Nascent Breakthrough Energy Ventures Future Ventures Galaxy Interactive +9 more

Compstakcompstak.com in 𝕏Oct 2014

CompStak is a crowdsourced commercial real estate data platform that aggregates millions of data points weekly to provide comprehensive CRE datasets for lenders, investors, and landlords.

Data & InfrastructureEnterprise SoftwarePropTechNew York, US

Michael Mandel(Co-founder & CEO)inVadim Belobrovka(Co-founder & CTO)

BoardHrach Simonian(Director)

Co-investors500 Global Camber Creek Escalate Capital Partners Expansion Venture Capital Founder Collective Global Brain +4 more

Concord Communicationsacquired by Computer Associates (CA) · Jun 2005 · $350M

Concord Communications developed network-management software, including its eHealth and Network Health product lines, that monitored and reported on the performance and availability of enterprise IT and telecom infrastructure.

Contentsquarecontentsquare.com in

Contentsquare offers a digital experience analytics platform that uses AI to help teams understand customer behavior across websites and apps through heatmaps, zoning analysis, journey mapping, and session insights.

AI & Machine LearningData & InfrastructureMarketing TechSaaSParis, FR

Jonathan Cherki(Founder)in

Co-investorsBleu Capital Columbia Lake Partners Elizabeth Street Ventures Highland Europe Sixth Street SoftBank Vision Fund +7 more

Copper Mountain Networkacquired by Tut Systems · Feb 2005 · $10M

Copper Mountain Networks was a Palo Alto-based maker of DSL networking equipment that let telecom carriers and ISPs deliver voice, video, and data over existing copper phone lines.

Cortina Systemsacquired by Inphi · Oct 2014 · $131M

Cortina Systems designed integrated circuits for broadband and optical networking equipment, including multi-service port processors supporting Ethernet and SONET protocols.

Corviumcorvium.com

Jeff Swartzin

Co-investorsAcre Venture Partners NSG Ventures Cultivian Sandbox Ventures

Coteriecoterieparty.com 𝕏

Coterie sells disposable party goods such as paper plates and tableware, offered in designed collections and customizable sets for consumers planning parties.

ConsumerDirect to ConsumerE-commerce

Linden EllisinSara Raffa

Co-investorsFemale Founders Andreessen Horowitz

Countablecountable.com

Actionable is a self-service advocacy platform that lets organizations launch, manage, and measure campaigns such as petitions, pledges, lawmaker messages, and supporter mobilization without developers or consultants.

GovTechImpact & Social GoodSaaSOakland, US

Bart Myers(Executive Officer, Director)

Board Joydeep Bhattacharyya(Director)in

Co-investorsFernbrook Capital Management Silicon Valley F-Prime Capital

CrossLogixacquired by BEA Systems, Inc. · Feb 2003 · $8.9M

CrossLogix developed enterprise authorization and entitlement software that controlled and audited access to internet-based applications, content, and data based on centralized business policy.

Curtsycurtsyapp.com in 𝕏

Curtsy is a mobile marketplace where users buy and sell secondhand fashion items.

Circular EconomyConsumerDirect to ConsumerE-commerceMarketplacesSan Francisco, US

David Oates(Founder/CEO)inEli Allen(Founder)in

Co-investorsIndex Ventures Y Combinator

Cuyanacuyana.com

Cuyana is a direct-to-consumer luxury leather goods and accessories brand that designs customizable bags and accessories made from sustainable materials.

Circular EconomyConsumerDirect to ConsumerSan Francisco, US

Shilpa Shah(Founder)inKarla Gallardo(Founder)in

Co-investorsComcast Ventures Greycroft H.I.G. Capital H.I.G. Growth Partners SHAKTI

Cynomicynomi.com in

Cynomi offers an AI-driven security program management platform that lets managed service providers and security consultancies run assessments, generate risk registers, remediation roadmaps, policies, and compliance mappings, and manage the full security program lifecycle across their client portfolios.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaS

David Primor(Co-founder and CEO)inRoy Azoulay(Co-founder and COO)inOhad Chereshniya(CFO)inShane Deegan(CRO)inErin McLean(CMO)inReut Roich(VP Product)in

Co-investorsEntrée Capital Insight Partners Flint Capital Lytical Ventures Selah Ventures

CytomX Therapeutics Holdings

Santa Barbara, US

Alan Heeger(Vice President and Manager)Gary Wilcox(Vice President and Manager)

Co-investorsThird Rock Ventures

Data & Security Earlyedgeimpulse.com

Edge Impulse provides intelligent asset tracking solutions using real-time sensor, audio, and vision data to enhance supply chain visibility, livestock management, environmental monitoring, and public safety across logistics, agriculture, and infrastructure sectors.

AI & Machine LearningDeveloper ToolsIoTLogistics & Supply Chain

Zach ShelbyJan Jongboom

Co-investorsAcrew Capital Cerity Partners Ventures Coatue Management In-Q-Tel

Data Sciences Internationaldatasci.com in

DSI provides scientific services for preclinical research, including implanted telemetry support, in vivo study execution, data analysis and reporting, and GLP validation.

BiotechHardwareHealthtechMedical DevicesSt. Paul, US

Co-investorsPartners for Growth Partners for Growth (PFG)

Dermiradermira.com

HealthtechMenlo Park, US

Thomas G. Wiggans(Executive Officer, Director)inEugene A. Bauer(Executive Officer, Director)Andrew Guggenhime(Executive Officer)Luis Pena(Executive Officer)Christopher Griffith(Executive Officer)

Board Fred Craves(Director)in

Co-investorsAisling Capital Bay City Capital Foresite Capital New Enterprise Associates (NEA)Fidelity Investments Qiming Healthcare +1 more

Dexterraacquired by Antenna Software · Jun 2009

Dexterra developed enterprise mobile middleware and application-development tools that let companies build and deploy mobile apps for field workforces, syncing data with backend CRM and supply-chain systems.

Diffusion Softwarediffusionsoftware.com

Diffusion Software develops desktop applications including Airomate and Chronos, and maintains a list of compatible soundcards.

SaaS

Diligent Roboticsdiligentrobots.com inFeb 2025Acquired

Diligent Robotics develops AI-powered robot assistants for healthcare settings, focusing on mobile manipulation and social intelligence to help hospital staff with routine non-patient-facing tasks.

AI & Machine LearningHealthtechMedical DevicesRoboticsAustin, US

Andrea L. Thomaz(Founder)inVivian Chu(Founder)in

BoardQuaeed Motiwala(Director)Rohit Sharma(Director)Lance VandenBrook(Director)Richard Boyle(Director)

Co-investorsATP Correlation Ventures Dnx Ventures Grit Ventures Next Coast Ventures Pathbreaker Ventures +6 more

DoorStepdoorstep.ai in 𝕏

Doorstep offers an SDK that uses smartphone sensor fusion to detect delivery events indoors in GPS-degraded environments, tracking parking, entrance, floor, and drop-off details.

AI & Machine LearningDeveloper ToolsLogistics & Supply Chain

Shashwat M.(Founder)inSheel Patel(Founder)in

DoubleClickdoubleclickbygoogle.com

David Rosenblattin

Co-investorsJMI Equity ScOp Venture Capital Silver Lake Partners

Drivetimedrivetime.fm in

San Francisco company building hands-free, voice-controlled trivia games that drivers play with their voices while commuting.

Co-investorsThe Chernin Group (TCG Crypto)Makers Fund

Durata Therapeuticsduratatherapeutics.com

Co-investorsAisling Capital

Dusty Roboticsdustyrobotics.com in 𝕏

Dusty Robotics builds the FieldPrinter, a mobile robot that automates layout and marking tasks on construction job sites.

Construction TechHardwareRoboticsMountain View, US

Tessa Lau(Executive Officer, Director, Promoter)in Philipp Herget(Director, Promoter)in

BoardAvidan Ross(Director)Richard Boyle(Director)in

Co-investorsCantos Ventures GRIDS Capital Humba Ventures NextGen Venture Partners Root Ventures Manager, Llc Scale Venture Partners +1 more

Earnipayearnipay.com

Lekki, NG

Nonso O(Founder)

Co-investorsXYZ Venture Capital Musha Ventures Ventures Platform

eBatesebates.com in 𝕏acquired by Rakuten

Rakuten (formerly Ebates) is a cash-back rewards service that lets shoppers earn money back at over 3,500 online stores, with rewards stacking on top of sales, coupons, and credit card rewards.

ConsumerE-commerceFintechMarketplaces

Co-investorsAugust Capital Windspeed Ventures

Echopassacquired by Genesys · Oct 2013

Echopass Corporation provided cloud-based, software-as-a-service contact center technology, including hosted call routing, IVR, and agent performance tools for large enterprises and government agencies.

EdgeImpulse inDec 2021 · $34MAcquired

Embedded machine learning for intelligent devices

San Jose, US

Zachary Shelby(Executive Officer, Director)

Co-investorsAcrew Capital Cerity Partners Ventures Fika Momenta Ventures Coatue Management Fika Ventures +1 more

Elevation Pharmaceuticalsacquired by Sunovion Pharmaceuticals Inc. · Sep 2012 · $100M

Elevation Pharmaceuticals was a San Diego-based clinical-stage biopharmaceutical company founded in 2008 that developed inhaled aerosol therapies, including the bronchodilator EP-101, for COPD patients.

Embrokerembroker.com in 𝕏Jun 2021 · $100M

Embroker is a digital-first business insurance provider that lets companies compare, purchase, and manage commercial insurance policies online, combining an insurance platform with expert broker support.

AI & Machine LearningFintechInsurTechSaaS

Matt Miller(Founder)inYotam Shacham(Founder)inBen Jennings(CEO)in

Co-investorsFTV Capital 500 Global Bee Partners Chaos Ventures Clocktower Ventures MassMutual Ventures +8 more

Emissaryemissary.io

Emissaryemissaryhealth.org

New York, US

Tony Jaros(Executive Officer, Director)Dino Di Palma(Director)Allen Mueller(Executive Officer, Director)

BoardRobert Hower(Director)Maia Heymann(Director)in

Co-investorsThe MBA Fund Converge G20 Ventures GV (Google Ventures)The New York Times

Engine by MoneyLionengine.tech in

Engine by Gen is the B2B brand of Gen (NASDAQ: GEN), operating an embedded finance marketplace platform that matches consumers with real-time, personalized financial product recommendations from a network of providers.

AI & Machine LearningFintechMarketing TechMarketplacesSaaS

Co-investorsEdison Partners

Enpirion

Co-investorsIntel Capital

Browse all 435 investments with full details →

▶235 more tracked companies

EnterpretEnvisiaEon LaboratoriesEphemeralEsperion TherapeuticseStampEverdream CorporationExecthreadExecThread, Inc.Field AI Fireflies AiFLA HoldingsFrame Technology Fxlabs Gen.G Genome Genome Medical, Inc.GenVecGoodwin Company Grey Wolf Therapeutics GrokStyle GroundWork Open SourceHabeasHalda Therapeutics Hermeus Mach 5 engine HeyMiloHighriseHomeis exitedHugo Human Security ID AnalyticsImmunicon CorporationInstante SoftwareInstrumentalIntelliCareInteract CommerceInternational Network ServicesIntralinksIntrawareIntrepidiaBioiPrint TechnologiesIstante SoftwareItalicIterum Therapeutics JinaJobDirectJobdirect ComJoinJoin Digital JOORJumpcutJunoKabamKabamKalpanaKepler Kepler Communications Kickpay Kin EuphoricsKinecta CorporationLabrys BiologicsLadderLancopeLatitude CommunicationsLeanplum Leap To Win TechnologiesLeap To Win Technologies Private LimitedLendingClub Lev Lily AI liveramp.com/ (opens in new tab)LiveUMachEyeMani.MeMantra MantraMariner Health GroupMarinus PharmaceuticalsMarvinMarvinMatch.comMateMate SecurityMatrimony ComMatrix PharmaceuticalMC SciencesMetacloudMightyTV MindTickleMiraMobilitecMoseyMoviePass Mschf Product Studio Inc NatureBoxNetwork EnginesNivoda LimitedNocionNode NormunityNorthstar NeuroscienceNova Labs Novee Novee Novee Security Novira Therapeutics OllieOn DeckON24OncolineaOncoLinea PharmaceuticalsOnDeck (nZero)OnDemandOnefinestay OnePipeOneSource ServicesONI Systems CorporationOnramp Payments, Inc.OpenartOpenSkyOrapharma Inc Orchard (formerly Perch)Orthocon, Inc.Page Technologies, Inc.PapaPartiful CoPathios Therapeutics Paxos Peer39Peninsula PharmaceuticalsPlayers' LoungePlixiPodzPozenPraecis PharmaceuticalsPrax Health Premier Laboratory ServicesPrimeSenseProperty CapsuleProvenance Technologies, Inc.Quarry TheraRADD PharmaceuticalsRally Network, Inc.RamReRapidataRapidataReactive BioReactive Biosciences Reflex Reflex Careers, Inc.ReibusReplicantRevivantRightPointRLY Network RLY NetworkRoRocketrip Rondo TherapeuticsRondo Therapeutics, Inc.RyloSafire SageOxSandforceSavvyScaleFactor Semnur PharmaceuticalsSensageShara Inc.ShopKeepSidechatSilicon OptixSilverRailSitterSkale LabsSkybox Imaging SnykSolvelySolvely AiSpectrianSpinifex PharmaceuticalsSuccessFactorsSuiza FoodsSumbleSuperplasticSwitchfly SynthekineTacit NetworksTAGTallanTariTelaria TelitTerretThe InsideThe MetaThe RealRealTiaTobira TherapeuticsTomorrow Io Tremor Triton Therapeutics, Inc.TropicTropic BiosciencesTrueFortTubular LabsTuroTuro (RelayRides)Twenty20TyraUnifiUniform TeethURoamValid Vedana Therapeutics, Inc.VictoriousVima Therapeutics, Inc.Virsto SoftwareVirtuoso Therapeutics, Inc.Visigenic SoftwareVisipriseVoyenceVue TechnologyWebloyaltyWebloyalty ComWiseLayer withcoWizRocket, Inc. (d/b/a CleverTap)WonderhillWorkMotionWorld ViewXirrusZANDIVIO LTD (d/b/a Uniform Teeth)ZmandaZugata

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 41

IPOs and acquisitions across the tracked portfolio

Arvinas Holding Co. LLCNASDAQ: ARVNCardlyticsNASDAQ: CDLXCytomXNASDAQ: CTMXLiquidia CorporationNASDAQ: LQDALiquidia TechnologiesNASDAQ: LQDANextCureNASDAQ: NXTCRallybio HoldingsNASDAQ: RLYBTYRA BiosciencesNASDAQ: TYRAAevaNASDAQ: AEVADexComNASDAQ: DXCMIdeaya BiosciencesNASDAQ: IDYAInstacartNASDAQ: CARTMatchNASDAQ: MTCHProtagonist TherapeuticsNASDAQ: PTGXRallybio, LLCNASDAQ: RLYBOllieacq. by AgrolimenTranscend Medicalacq. by AlconAdvanced BioHealingacq. by ShireAim Securityacq. by Cato NetworksAlsius Corporationacq. by ZOLL Medical CorporationApieronacq. by AerocrineArbor Networksacq. by NetScout SystemsArgon Networksacq. by SiemensAssociated Contentacq. by YahooAtheroMedacq. by Volcano CorporationBeckonacq. by IgniteTechCalibra Medicalacq. by Johnson & JohnsonCalixa Therapeuticsacq. by Cubist Pharmaceuticals, Inc.CAPMAC Holdingsacq. by MBIA Inc.Cell Pathwaysacq. by OSI Pharmaceuticals, Inc.Cellular Researchacq. by Becton, Dickinson and Company (BD)Cerexaacq. by Forest LaboratoriesCombinatoRxacq. by Horizon Discovery Group plcConcord Communicationsacq. by Computer Associates (CA)Copper Mountain Networkacq. by Tut SystemsCortina Systemsacq. by InphiCrossLogixacq. by BEA Systems, Inc.Dexterraacq. by Antenna SoftwareeBatesacq. by RakutenEchopassacq. by GenesysElevation Pharmaceuticalsacq. by Sunovion Pharmaceuticals Inc.

Portfolio news

latest coverage across their companies

India's D2C Brand Ecosystem. A ValPro Enablers Report - September 2026 - Enablers

Node · enablersinvestment.com · Sep 9, 2026

Mantra Blockchain Halt Raises Security Concerns Amid Market Rally

Mantra · en.cryptonomist.ch · Aug 21, 2026

Merck Stock Jumps on Phase 3 Cancer Vaccine Win as Keytruda Risk Eases

Cidara Therapeutics · tradingkey.com · Aug 20, 2026

Markets Rally After U.S. Treasury Eases Bond Investor Stress - The New York Times

Bond · nytimes.com · Aug 19, 2026

Kepler Cheuvreux Boosts Ipsen PT, Maintains Hold Rating | MarketScreener

Kepler · marketscreener.com · Aug 17, 2026

JPMorgan Chase & Co. Cuts CytomX Therapeutics (NASDAQ:CTMX) Price Target to $11.00 - Ticker Report

CytomX · tickerreport.com · Aug 16, 2026

BioMarin Targets Faster Deleveraging as Amicus Deal Expands Rare-Disease Growth - Daily Political

Amicus Therapeutics · dailypolitical.com · Aug 15, 2026

TYRA Biosciences investor reports 6% ownership stake | TYRA SEC Filing - Form SCHEDULE 13G/A

TYRA Biosciences · stocktitan.net · Aug 14, 2026

Fund performance · per public LP disclosures · 9

as of Jun 2025

Fund	Vintage	Committed	Net IRR	TVPI	DPI
Canaan XIII Healthcare Fund L.P.LPs: California Public Employees' Retirement System	2024	—	—	0.59x	0.00x
Canaan XIII L.P.LPs: California Public Employees' Retirement System	2024	—	—	0.90x	0.01x
Canaan Gold Coast L.P.LPs: California Public Employees' Retirement System	2023	—	—	1.03x	0.00x
Canaan XII L.P.LPs: Los Angeles County Employees Retirement Association	2020	—	3.4%	1.10x	0.00x
Canaan XI, L.P.LPs: Los Angeles County Employees Retirement Association	2017	—	9.7%	1.68x	0.06x
Canaan IXLPs: The Regents of the University of California, Hawaii Employees' Retirement System	2012	—	19.1%	2.04x	0.93x
Canaan VIII, L.P.LPs: The Regents of the University of California, Hawaii Employees' Retirement System	2007	—	8.9%	1.44x	1.24x
Canaan Equity Partners VIILPs: The Regents of the University of California	2005	—	16.0%	2.44x	1.50x
Canaan VII, L.P.LPs: The Regents of the University of California, Los Angeles County Employees Retirement Association, Hawaii Employees' Retirement System	2005	—	14.6%	2.53x	2.33x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

IPO stake values · per SEC filings · 7

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

Company	Owned	IPO price	At IPO	Stake value
NextCure	8.4%	$36.75	Nov 2019	$82.9M
TYRA Biosciences	10.8%	$16.00	Sep 2021	$70.6M
CytomX	14.0%	$12.00	Oct 2015	$58.6M
Rallybio, LLC	7.5%	$13.00	Jul 2021	$30.3M
Rallybio Holdings	7.5%	$13.00	Jul 2021	$30.3M
Protagonist Therapeutics	14.9%	$12.00	Aug 2016	$29.4M
Ideaya Biosciences	11.6%	$10.00	May 2019	$22.6M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has Canaan Partners made?: Canaan Partners has 369 tracked investments, 103 of which have exited via acquisition or IPO, including 21 dated in the last 24 months.
What stage does Canaan Partners invest at?: Canaan Partners invests at the Pre-Seed, Seed, Series A stages.
What is Canaan Partners's typical check size?: Canaan Partners typically writes checks of $500K – $20M.
What sectors does Canaan Partners focus on?: Canaan Partners focuses on Biotech, Cloud Computing, Consumer, Deep Tech, Digital Health, E-commerce, Enterprise Software, Fintech, Gaming, Healthtech, Medical Devices.
Where is Canaan Partners located?: Canaan Partners is headquartered in Stamford, US.
Does Canaan Partners lead rounds?: Yes, Canaan Partners leads investment rounds.
Who does Canaan Partners co-invest with?: Canaan Partners most often shares deals with Connecticut Innovations, Evolution VC Partners, New Enterprise Associates (NEA), among 594 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Zuckerberg's Puerto Rico VR video was in poor taste but uncharacteristic for him: Canaan Partners' Maha Ibrahim

Maha Ibrahim · cnbc.com

Wende Hutton, Canaan Partners

Life Science Washington · Wende Hutton

Deepak Kamra, Canaan Partners: Innovation

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Keys to Success

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Lessons Learned

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Rapid Fire Questions

Tech4Obama · Deepak Kamra

Images

Co-investors · 265

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

Both backed · 11

Liquidia Corporation Amicus Therapeutics Berkshire Grey Dermira Envisia Therapeutics Gen.G Lily AI MindTickle Node Relievant MedsystemsVirgin Pulse

$200K – $40M

RA Capital

RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.

Both backed · 10

Arvinas Holding Co. LLC Protagonist Therapeutics TYRA Biosciences Cidara Therapeutics Civitas Therapeutics Day One Biopharmaceuticals Halda Therapeutics Solstice Oncology Synthekine Vivace Therapeutics

Khosla Ventures

Khosla Ventures is a venture capital firm founded by Vinod Khosla.

Both backed · 9

Instacart Azibo Commonwealth Field AI Fireflies Ai Hermeus Mach 5 engine Nova Labs Skybox Imaging Snyk

$5K – $50M

Coatue Management

Coatue Management is a technology-focused investment firm that invests in innovation across both public and private markets with responsible risk management.

Both backed · 9

Instacart Bond EdgeImpulse Kustomer LendingClub ScaleFactor Snyk SumbleData & Security Early

$1M – $20M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

Both backed · 8

Antiva Biosciences Emissary Genome Kabam Nova Labs RelayRides Rocketrip Snyk

$250K – $50M

Insight Partners

Insight Partners is an investment firm focused on accelerating revenue and profit growth in software companies, providing capital and operational support through its Insight Onsite team.

Both backed · 8

Aceiss Appsmith Cynomi Lily AI Mate nTopology ReplicantVirgin Pulse

$120M – $350M

5AM Ventures

5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.

Both backed · 8

Arvinas Holding Co. LLC Ideaya Biosciences Rallybio Holdings Rallybio, LLC Chrono Therapeutics Cidara Therapeutics Novira Therapeutics Spyryx Biosciences

$100K – $4M

Connecticut Innovations

Connecticut Innovations is the state of Connecticut's investment arm, providing capital and strategic support to early stage and growth companies across multiple funds.

Both backed · 8

Arvinas Holding Co. LLC Rallybio, LLC Aceiss Alphina Therapeutics Halda Therapeutics Marinus Pharmaceuticals Normunity Quantum Circuits

$500K – $2M

Lightspeed Venture Partners

Lightspeed is a global venture capital firm that has spent over two decades backing innovative companies as an early and first investor.

Both backed · 7

Apex Ai Brigit Clutch Ladder LiveU MyndArbor Networks

$1.7M – $87M

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

Both backed · 6

Appsmith Rocketrip ScaleFactorBharat MatrimonyMatrimony ComVirgin Pulse

$5M – $100M

Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

Both backed · 6

Appsmith Bird Scooters MindTickle Snyk World View EnterprisesSilverRail

$1.6M – $70M

Norwest Venture Partners

Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.

Both backed · 6

Kustomer Leanplum LendingClub MindTickle Replicant World View Enterprises

$10M – $30M

▶253 more co-investors

F-Prime Capital August Capital Comcast Ventures OrbiMed OUP (Osage University Partners)Andreessen Horowitz General Catalyst Redpoint Ventures Kleiner Perkins Spark Capital Shasta Ventures ARCH Venture Partners Correlation Ventures Sofinnova Ventures Nextech Invest Lightstone Ventures Felicis Ventures FJ Labs DCVC (Data Collective)Battery Ventures SoftBank Vision Fund Intel Capital Nyca Partners Novo Holdings Alumni Ventures Greycroft Headline Scale Venture Partners Acrew Capital Atlas Venture US Venture Partners Winklevoss Capital Inspired Capital Dreamers VC Tribeca Venture Partners Root Ventures Manager, Llc Third Rock Ventures Advance Venture Partners In-Q-Tel Conductive Ventures New Leaf Venture Partners Alta Partners Kaiser Permanente Ventures Index Ventures First Round Capital Sound Ventures CRV (Charles River Ventures)Great Oaks Venture Capital ACME Capital FirstMark Capital RRE Ventures FundersClub Addition Cota Capital Sierra Ventures Trinity Ventures Revolution Social Leverage 500 Global Costanoa Ventures boldstart ventures Webb Investment Network Dnx Ventures Torch Capital Cisco Investments NewView Capital XYZ Venture Capital Zeev Ventures Next Coast Ventures MassMutual Ventures GE Ventures National Grid Partners Square Peg Capital Fontinalis Partners SR One Capital Management venBio Partners The Column Group Domain Associates Pivotal Life Sciences BlueYard Capital Hatteras Venture Partners Vida Ventures Base Venture Management, Inc.Pontifax Venture Capital Thompson Hutton, LLC Avoro Capital Advisors Casdin Capital Sequoia Capital Craft Ventures Founder Collective Foundation Capital BoxGroup True Ventures Plug and Play Ventures Quiet Capital Offline Ventures Mayfield Fund Liquid Ventures AME Cloud Ventures Fifth Wall PICUS CAPITAL Trajectory Ventures Next47 Venrock Polaris Partners DN Capital Base10 Partners Blockchain Capital Cyberstarts Primary Venture Partners Citi Ventures Fuel Capital Renegade Partners Pelion Venture Partners Digital Currency Group Energy Impact Partners Acequia Capital (AceCap)Flourish Ventures Work-Bench Tusk Venture Partners Mango Capital Storm Ventures NGP Capital Pitango Flare Capital Partners Ten Eleven Sutter Hill Ventures JAZZ Venture Partners EQT Life Sciences Indicator Ventures Versant Ventures Walden Catalyst Johnson & Johnson Innovation – JJDC Deerfield Management Company Tola Capital Mithril Capital Management Abingworth Clearvision Ventures Two Bear Capital One Planet Group Access Industries Advent Life Sciences MTECH CAPITAL RiverVest Venture Partners Momenta Ventures IA Capital Group Vensana Capital Vertical Venture Partners BrandProject Capital JMI Equity RET Ventures Adjuvant Capital Emerson Collective Investing Greylock Partners Long Journey Ventures Notable Capital Uncork Capital Benchmark Sapphire Ventures Partech Ventures HCVC SciFi VC Forerunner Ventures Precursor Ventures Emergence Capital Partners Obvious Ventures Resolute Ventures Bowery Capital Bonfire Ventures Crosslink Capital Paradigm 75 & Sunny Tribe Capital Firstlook General Partnership Chemistry AngelPad Eclipse Ventures Better Tomorrow Ventures Operator Collective Ballistic Ventures 8-Bit Capital Baseline Ventures Zetta Venture Partners Wildcat Venture Partners Company Capital American Express Ventures (Amex)Xtripe Angels The Finger Group House Z47 Mischief S28 Capital Ravelin Capital Rubicon Venture Capital Origin Ventures Vertex Ventures Sea Management Pte. Ltd.G2 Venture Partners Parade Ventures Artis Ventures Angular Ventures AZ-VC S32 WestWave Capital AI Fund Paladin Capital Group Miramar Venture Partners Space Tech Ventures Episode1 Illuminate Ventures Sofinnova Partners Grotech Ventures Nazca Helion Venture Partners Redpoint eventures Space Capital KOMPAS VC ANIMO Ventures Autotech Ventures XSeed Capital Asset Management Ventures XAnge Stanford University Acrobator Ventures Morgenthaler Frazier Healthcare Partners Glencrest Group Northside Ventures Top Tier Capital Partners Ankona Capital Pritzker Group Venture Capital SmartStart Fund Dolby Family Ventures Omega Funds Tunitas Ventures Jefferies Northwestern Mutual Accelerator 125 Ventures HealthQuest Capital StarVest Partners alpha4 ventures ALLVP Merian Ventures Staircase Ventures Westlake Village BioPartners Goldcrest Capital Okapi Venture Capital D.E. Shaw Startup Capital Ventures Pappas Capital Union Square Advisors LLC Avedro, Inc.Red Tree Venture BioInnovation Capital

Firms observed investing alongside Canaan Partners, from public investor directories. Shared companies are the overlap with Canaan Partners's recorded portfolio.

Similar investors

MPG Fund

MPG Fund is an early-stage venture investor backing technology startups.

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.

$250K

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M

OMERS Ventures

OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.

$5M – $25M

Norwest Venture Partners

Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.

$10M – $30M

Featured in lists

Investors & VC Firms in North America Investors & VC Firms in United States Seed Investors & VC Firms Series A Investors & VC Firms Pre-Seed Investors & VC Firms Seed Investors & VC Firms in North America Seed Investors & VC Firms in United States Series A Investors & VC Firms in North America Series A Investors & VC Firms in United States Fintech Investors & VC Firms Healthtech Investors & VC Firms Enterprise Software Investors & VC Firms